<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2025.1625938</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Galectin-8 deficiency promotes chronic splenomegaly persistence in Chagas disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Bertelli</surname>
<given-names>Adriano</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/262779/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Saborit</surname>
<given-names>Juan Ignacio</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2955705/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Beccaria</surname>
<given-names>Cristian Gabriel</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/461619/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vanagas</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/680659/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Angel</surname>
<given-names>Sergio Oscar</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/244070/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Campetella</surname>
<given-names>Oscar</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/147534/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gruppi</surname>
<given-names>Adriana</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/262779/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Leguizam&#xf3;n</surname>
<given-names>Mar&#xed;a Susana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/877399/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Instituto de Investigaciones Biotecnol&#xf3;gicas (IIBio), Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Escuela de Bio y Nanotecnolog&#xed;as (EByN), Universidad Nacional de San Mart&#xed;n (UNSAM)</institution>, <addr-line>Buenos Aires</addr-line>,&#xa0;<country>Argentina</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Centro de Investigaciones en Bioqu&#xed;mica Cl&#xed;nica e Inmunolog&#xed;a (CIBICI), Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET)</institution>, <addr-line>C&#xf3;rdoba</addr-line>,&#xa0;<country>Argentina</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Instituto de Investigaciones Tecnol&#xf3;gicas de Chascom&#xfa;s (INTECH), Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Escuela de Bio y Nanotecnolog&#xed;as (EByN), Universidad Nacional de San Mart&#xed;n (UNSAM)</institution>, <addr-line>Buenos Aires</addr-line>,&#xa0;<country>Argentina</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/383486/overview">Ana Claudia Torrecilhas</ext-link>, Federal University of S&#xe3;o Paulo, Brazil</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/428846/overview">Cristina Mary Orikaza</ext-link>, Federal University of S&#xe3;o Paulo, Brazil</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/521718/overview">Mariana Citlalli De Alba Alvarado</ext-link>, National Autonomous University of Mexico, Mexico</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1845710/overview">Jian He</ext-link>, Sun Yat-sen University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Mar&#xed;a Susana Leguizam&#xf3;n, <email xlink:href="mailto:sleguiza@unsam.edu.ar">sleguiza@unsam.edu.ar</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>10</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1625938</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>05</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>08</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Bertelli, Saborit, Beccaria, Vanagas, Angel, Campetella, Gruppi and Leguizam&#xf3;n.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Bertelli, Saborit, Beccaria, Vanagas, Angel, Campetella, Gruppi and Leguizam&#xf3;n</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Galectins (Gals) are mammalian lectins with affinity for <italic>&#x3b2;</italic>-galactosides, which drive the immune response through several mechanisms. The specific role of Gal-8 in the development of inflammation remains controversial, as it has been shown to induce either T cell proliferation or regulation in different models. During the acute phase of <italic>Trypanosoma cruzi</italic> infection, a characteristic splenomegaly is induced that is associated with both antigen-specific and non-specific polyclonal lymphocyte proliferation. This splenomegaly resolves as the infection transitions to the chronic phase. While the pathogenesis of Chagas disease is not yet fully understood, it is widely accepted to involve both parasite persistence and the host immune response. In this study, C57BL/6J and Gal-8-deficient (KO) mice infected with the Ac strain were analyzed during the chronic phase (4 months post-infection). Notably, infected Gal-8KO mice failed to resolve the <italic>T. cruzi</italic>-induced acute phase splenomegaly. Despite this, parasitemia, spleen parasite load, and survival rates were comparable between the two groups, suggesting that Gal-8 is not involved in parasite control. The observed differences in spleen cellularity were primarily attributed to T lymphocyte proliferation, while B cells exhibited no significative changes in total cell number, proliferation levels and production of total and parasite-specific antibodies. Overall, our results reveal that Gal-8 plays an anti-inflammatory role during chronic <italic>T. cruzi</italic> infection and is critical in controlling splenomegaly, a process for which no associated regulatory molecules have been identified to date.</p>
</abstract>
<kwd-group>
<kwd>Chagas disease</kwd>
<kwd>Galectin-8</kwd>
<kwd>inflammation</kwd>
<kwd>splenomegaly</kwd>
<kwd>Trypanosoma cruzi</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="94"/>
<page-count count="16"/>
<word-count count="9061"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Parasite and Host</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>
<italic>Trypanosoma cruzi</italic> is an intracellular protozoan parasite, the etiologic agent of Chagas disease, that affect 7 million people worldwide. It is a main public health problem in Latin America, which spreads to developing countries, mainly through blood transfusion from infected patients who migrates to non-endemic areas (<xref ref-type="bibr" rid="B26">de Sousa et&#xa0;al., 2024</xref>). The parasite induces the development of chronic megaviscera and/or cardiomyopathy in &#x223c;30% of patients. Chronic Chagas cardiomyopathy is the most frequent and severe, and is a consequence of an intense, and permanent inflammation process throughout the infection caused by local parasite persistence (<xref ref-type="bibr" rid="B35">Garcia et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B49">Marin-Neto et&#xa0;al., 2007</xref>). It has been accepted that the parasitic load is responsible for triggering the inflammatory response (<xref ref-type="bibr" rid="B78">Tarleton and Zhang, 1999</xref>).</p>
<p>Galectins (Gals) are mammalian lectins containing conserved carbohydrate recognition domains (CRDs) that interact with &#xdf;-galactose-containing glycans displayed on different cells. Galectin-8 (Gal-8) together with Gal-4 and Gal-9, belong to the tandem-repeated group. Gal-8 contains two CRDs, with different glycan specificity, that are fused via a peptide linker (<xref ref-type="bibr" rid="B10">Bidon et&#xa0;al., 2001</xref>) and, unlike other Gals, is widely distributed in different tissues under normal conditions, as well as in tumors and synovial fluid (<xref ref-type="bibr" rid="B85">Tribulatti et&#xa0;al., 2020</xref>). It is also expressed in endothelium and released into the environment when tissue is damaged (<xref ref-type="bibr" rid="B79">Thijssen et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B17">Cattaneo et&#xa0;al., 2014</xref>) and has been involved in different events, both pathological and homeostatic (<xref ref-type="bibr" rid="B29">Elola et&#xa0;al., 2014</xref>). It has been communicated Gal-8 ability to bind to surface ligands of <italic>T. cruzi</italic> (<xref ref-type="bibr" rid="B61">Pineda et&#xa0;al., 2015</xref>) as well as to exposed glycans in damaged bacterial-infected vacuoles, acting as danger receptors (<xref ref-type="bibr" rid="B80">Thurston et&#xa0;al., 2012</xref>). Gal-8 plays both pro- or anti-inflammatory roles depending on the context (Reviewed in (<xref ref-type="bibr" rid="B85">Tribulatti et&#xa0;al., 2020</xref>), see also (<xref ref-type="bibr" rid="B94">Zick, 2022</xref>). We have reported the association of Gal-8 in inducing T cell expansion under both antigen-specific and nonspecific conditions and showed that this T cell co-stimulation is dependent on Gal-8 concentration (<xref ref-type="bibr" rid="B83">Tribulatti et&#xa0;al., 2009</xref>). On the other hand, an anti-inflammatory effect has been attributed to Gal-8 in autoimmune diseases such as rheumatoid arthritis (<xref ref-type="bibr" rid="B30">Eshkar Sebban et&#xa0;al., 2007</xref>), as well as in uveitis and encephalomyelitis models (<xref ref-type="bibr" rid="B71">Sampson et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B60">Pardo et&#xa0;al., 2017</xref>). In line with this, we demonstrated the anti-inflammatory role of Gal-8 during chronic <italic>T. cruzi</italic> infection by examining Gal-8-deficient (Gal-8KO) mice infected with the <italic>T. cruzi</italic> Ac strain (4 months post-infection, mpi) (<xref ref-type="bibr" rid="B9">Bertelli et&#xa0;al., 2020</xref>). While survival and parasitemia rates were similar between Gal-8KO-infected mice and wild-type (WT) C57BL/6J control mice, the absence of Gal-8 resulted in significant inflammation in the heart, skeletal muscle and liver, independently of parasite load. Remarkably, we observed an increased presence of neutrophils and macrophages in cardiac tissue of infected Gal-8KO (iGal-8KO) mice. The latter is associated with the absence of Gal-8-dependent preaparesis. These findings highlight the anti-inflammatory role that Gal-8 exerts during chronic <italic>T. cruzi</italic> infection (<xref ref-type="bibr" rid="B9">Bertelli et&#xa0;al., 2020</xref>).</p>
<p>During the early stages of infection, <italic>T. cruzi</italic> employs sophisticated strategies to evade and modulate the host immune response. Although unable to eliminate the parasite, the specific immune response allows the host survival and development of chronicity. Th1 effector mechanisms are relevant to parasite control (<xref ref-type="bibr" rid="B40">Kumar and Tarleton, 2001</xref>; <xref ref-type="bibr" rid="B38">Hoft and Eickhoff, 2002</xref>; <xref ref-type="bibr" rid="B91">Volta et&#xa0;al., 2021</xref>), but orchestrating a balanced  Th1 and Th2 immune response is crucial in <italic>T. cruzi</italic> infection, since an excessive or dysregulated activation, can lead to host tissue damage (<xref ref-type="bibr" rid="B69">Ruiz Diaz et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B44">Llaguno et&#xa0;al., 2019</xref>). The role of Th17 in protection, in murine and human studies have been also communicated (<xref ref-type="bibr" rid="B47">Magalhaes et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B13">Cai et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B27">Duarte et&#xa0;al., 2025</xref>). CD8<sup>+</sup> T cells play a central role in controlling the infection by targeting and eliminating the infected cells (<xref ref-type="bibr" rid="B4">Araujo Furlan et&#xa0;al., 2018</xref>). However, in the chronic phase, <italic>T. cruzi</italic> modulates the effectiveness of CD8<sup>+</sup> T cell responses, leading to incomplete pathogen clearance and immune exhaustion (<xref ref-type="bibr" rid="B2">Albareda et&#xa0;al., 2013</xref>). Regulatory T (Treg) cells play a dual role by helping to suppress excessive immune activation that could damage host tissue, while also aiding tissue repair once the infection is controlled. A transient decrease in Treg cells, during the acute phase, allows for a stronger activation of CD8<sup>+</sup> T cell responses, which is crucial for controlling the parasite (<xref ref-type="bibr" rid="B4">Araujo Furlan et&#xa0;al., 2018</xref>). B cell response and antibodies are important in targeting and controlling circulating parasites (<xref ref-type="bibr" rid="B88">Umekita and Mota, 2000</xref>; <xref ref-type="bibr" rid="B36">Gorosito Serran et&#xa0;al., 2017</xref>).</p>
<p>A prominent feature of acute <italic>T. cruzi</italic> infection is splenomegaly (<xref ref-type="bibr" rid="B45">Lopes et&#xa0;al., 1995</xref>; <xref ref-type="bibr" rid="B12">Cabrera et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B24">Dehesa-Rodriguez et&#xa0;al., 2022</xref>), driven by intense polyclonal proliferation of B cells, CD4<sup>+</sup> and CD8<sup>+</sup> T cells. This hyperactivation, which includes both antigen-specific and non-specific responses, contributes to immune dysregulation and facilitates parasite dissemination (<xref ref-type="bibr" rid="B51">Minoprio, 2001</xref>). Although the triggers for this massive lymphocyte expansion are not fully understood, parasite-derived components have been associated (<xref ref-type="bibr" rid="B65">Reina-San-Martin et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B55">Montes et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B56">Montes et&#xa0;al., 2006</xref>). Interestingly, splenomegaly typically resolves during the transition from acute to chronic infection, with the spleen regaining its normal size and function. Our study identifies Gal-8 as a critical regulator in this process. The absence of Gal-8 results in persistent splenomegaly during chronic <italic>T. cruzi</italic> infection. Given the importance of lymphocyte hyperactivation, often described as a polyclonal response during the acute phase, we conducted an in-depth analysis of the cellular events underlying chronic splenomegaly. Our findings highlight Gal-8 as a pivotal player in controlling splenic size and immune homeostasis.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Ethics statement</title>
<p>The study adhered to the principles of the Basel Declaration. Protocols No. 10/2017 and 08/2022 were approved by the Committee for Experimental Animal Care and Use (CICUAE) of the Universidad Nacional de San Mart&#xed;n (UNSAM), following the recommendations of the <italic>Guide for the Care and Use of Laboratory Animals</italic> of the National Institutes of Health (NIH).</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Mice</title>
<p>Male C57BL/6J (B6) mice were sourced from our in-house colony, established using breeder pairs obtained from The Jackson Laboratory (Bar Harbor, ME, USA). Male mice deficient in Gal-8 <italic>Lgals8</italic> gene [B6; 129S5-<italic>Lgals8Gt</italic> (OST314218) Lex/Mmucd] were acquired as heterozygotes from the Mutant Mouse Resource &amp; Research Centers (MMRRC; University of California, Davis, CA, USA). After 12 in-house backcrosses to B6, a homozygote Gal-8 knock-out (Gal-8KO) colony with &gt;95% of B6 genetic background was established, as assessed by The Jackson Laboratory Genotyping Resources. CF1 mice were bred from a colony obtained from Charles River Company. Mice were anesthetized with isoflurane, before manipulation. At least 4&#x2013;5 animals were included in each group.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>
<italic>Trypanosoma cruzi</italic> parasites and experimental infection</title>
<p>Male mice 10 to 16 weeks old were intraperitoneally infected with 50,000 <italic>T. cruzi</italic> Ac strain blood-derived trypomastigotes (DTU TcI) (<xref ref-type="bibr" rid="B66">Risso et&#xa0;al., 2004</xref>); which is maintained through serial passages in CF1 mice. Parasitemia was evaluated by counting trypomastigotes using a hemocytometer. Analysis of Gal-8 roles in <italic>T. cruzi</italic> murine model were conducted at 4 months post-infection (mpi). Age-matched wild type B6 (WT), and Gal-8KO mice were included as non-infected controls.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>
<italic>Toxoplasma gondii</italic> parasites and experimental infection</title>
<p>Male mice aged 10 to 16 weeks were orally infected with 5 <italic>T. gondii</italic> Me49 strain cysts (<xref ref-type="bibr" rid="B33">Fux et&#xa0;al., 2003</xref>); which are maintained through serial passages in mice. Parasite load was evaluated by counting cysts in brain samples. Brains were homogenized in 2 ml of PBS with a Dounce tissue grinder. The number of cysts per brain was counted under an optical microscope in 3 x 20 &#xb5;l aliquots of each homogenized brain. Mice were analyzed at 45, 60, 90 days post-infection (dpi) (<xref ref-type="bibr" rid="B25">de Medeiros Brito et&#xa0;al., 2022</xref>). Age-matched WT mice and Gal-8KO mice served as non-infected controls.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Flow cytometry</title>
<p>Spleens were mechanically disaggregated using a mesh, cells were centrifuged and incubated in red cells lysis buffer (Sigma) for 5 min at room temperature (RT). Cells were resuspended in PBS 2% FBS. Splenocytes were counted after erythrocyte lysis. Viable cell numbers were determined by trypan blue dye exclusion. We determined the total splenocyte number using a Neubauer chamber and expressed as total cells/spleen and as cells/ml. The percentage of each cell subpopulation was established by flow cytometry and subsequently the total number of cells in each subpopulation per spleen following the formula: % of cell subpopulation obtained by cytometry x total number of splenocytes (obtained by Neubauer chamber counting)/100 = total number of cell subpopulation in the spleen (Dual-platform method) (<xref ref-type="bibr" rid="B20">Cossarizza et&#xa0;al., 2021</xref>). For surface staining, cell suspensions were incubated with fluorochrome-labeled Abs (BioLegend) along with Live/Dead Fixable Aqua 405 (Invitrogen, dilution 1/400) in ice-cold PBS 2% FBS for 45 minutes at 4&#x2da;C. Samples were then washed, resuspended, and 50,000 events were acquired by flow cytometry. For intracellular staining, after surface staining, cells were fixed and permeabilized according to the manufacturer&#x2019;s instructions using the Foxp3/Transcription Factor Staining Buffer Set commercial kit (eBioscience). Subsequently, samples were incubated for 30 min at RT with specific antibodies for transcription factors. Finally, cells were washed, resuspended and 50,000 events were acquired by flow cytometry. After doublet exclusion, lymphocytes were identified based on forward (FSC-A) and side scatter (SSC-A) parameters. Live cells were gated by excluding those stained with Live/Dead Fixable Aqua 405. The following antibodies were used: FITC-labelled anti-mouse CD3, CD11c, CD21, CD44 and CD19; PE-labelled anti-mouse CD19, B220, Fas, CD11b, CTLA-4, Ki-67, and F4/80; PerCP-Cy5.5-labelled anti-mouse CD11b, CD23, CD138, CD62L, MHCII, F4/80 and Foxp3; APC-labelled anti-mouse CD8, GL7, Ly6C, Ly6G, CXCR5, and CD39; PE-Cy7-labelled anti-mouse CD19, CD206, B220, Ly6G, ICOS, and CD8; and APC-Cy7-labelled anti-mouse CD4, CD11c, Ly6C, and B220 (all from BioLegend). Samples were acquired using FACS Canto II and Fortessa cytometers (Becton Dickinson) and data were analyzed using FlowJo V10 software (BD).</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Proliferation assays</title>
<p>Splenocytes, 5x10<sup>5</sup> cells, were seeded in 96-well plates with RPMI 1640 plus 10% FBS, with or without <italic>T. cruzi</italic>-specific antigens stimulation (1&#xb5;g). <italic>T. cruzi</italic> trypomastigote pellets underwent 5 successive rounds of freezing and thawing using liquid nitrogen. Eighteen hours before harvesting, 50 &#xb5;L of complete RPMI 1640 medium containing 1&#xb5;Ci of [<italic>methyl</italic>-<sup>3</sup>H]-thymidine (New England Nuclear) was added/well. Cells were harvested using a semi-automatic cell harvester (Inotech Bioscience). Incorporated radioactivity was analyzed by recording cpm for each well. All treatments were performed in quadruplicate, and data were expressed as mean &#xb1; SEM.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Parasite load quantification</title>
<p>Genomic DNA was purified from spleens using DNAzol (GIBCO) reagent following the manufacturer&#x2019;s instructions. <italic>T. cruzi</italic>-specific DNA primers: TCZ-Forward 5&#x2019;-GCTCTTGCCCACAMGGGTGC-3&#x2019; (where M=A/C) and TCZ-Reverse 5&#x2019;-CCAAGCAGCGGATAGTTCAGG-3&#x2019;, which amplify a 182bp product, were used to quantify parasitic load by real-time qPCR employing SYBR Green (Applied Biosystems). Simultaneously, reactions containing 50 ng of mouse genomic DNA and 0.5 &#xb5;M of murine tumor necrosis factor (TNF) primers: TNF-5241 5&#x2019;-TCCCTCTCATCAGTTCTATGGCCCA-3&#x2019; and TNF-5411 5&#x2019;-CAGCAAGCATCTATGCACTTAGACCCC-3&#x2019; were used as loading controls. Primer sequences were previously described by <xref ref-type="bibr" rid="B21">Cummings and Tarleton (2003)</xref>. Results were expressed as parasite equivalents/50ng DNA.</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>ELISA</title>
<p>Splenocyte culture supernatants were collected, and cytokine secretion of IL-2, IL-4, IL-6, IL-10, IL-17, TNF and IFN&#x3b3; was measured by ELISA following the manufacturer&#x2019;s instructions (BioLegend) and using recombinant cytokines standard curves. Briefly, 96-well plates were coated with the corresponding antibody in phosphate buffer (pH 9) overnight (ON) at 4 &#xb0;C. Blocking was performed using TBS-Tween 20 (0.05%) with BSA (5%) for 1h at 37 &#xb0;C. Samples dilutions were then incubated for 2h at RT. Detection biotinylated antibodies were incubated in TBS-BSA (0.1%) for 1h at RT. Streptavidin-HRP conjugate (BioLegend) diluted 1:5000 was added for 1h at RT in the dark. Washing steps were performed with TBS-Tween 20 (0.05%) three times. Colorimetric reaction was developed with TMB (Sigma) and hydrogen peroxide in 10 mM citrate buffer (pH 5.5). Finally, the reaction was halted with 0.2 M sulfuric acid, and absorbance at 450 nm was measured using a FilterMax F5 (Molecular Devices).</p>
<p>For total IgG assays, plates were first coated with goat anti-total mouse immunoglobulins from Sigma. Seven serial dilutions (from 1:40 to 1:2560) of each serum sample were incubated for 2h. Washing steps were performed with TBS-Tween 20 (0.05%) three times. Anti-mouse IgG HRP-conjugated antibodies (BioLegend) were then added and incubated for 1h at RT. Colorimetric reaction was developed and measured as above. The cut off was determined using a serum pool obtained from uninfected mice from both groups. Avidity of sera taken from infected mice (4mpi) was assayed on <italic>T. cruzi-</italic>antigens<italic>-</italic>sensibilized plates (Wiener labs, Argentina) (<xref ref-type="bibr" rid="B48">Marcipar et&#xa0;al., 2001</xref>). Sera were tested at 1/5,000 dilution, that rendered OD<sub>450</sub> about 0.5, and after washing, a 6M urea in PBS solution was added at room temperature for 15 min. After washings, anti-mouse IgG HRP-conjugated antibodies (BioLegend) were then added at 1/5,000 dilution incubated for 1h and colorimetric reaction was developed and measured as above. The values are expressed as the ratio between the absorbance obtained without and with treatment with 6M urea. To determine IgG subclasses, samples were incubated for 2h on <italic>T. cruzi-</italic>antigens<italic>-</italic>sensibilized plates (Wiener labs, Argentina) and, after washings, biotinylated antibodies specific for the different subclasses (BioLegend) were added and then revealed with HRP-conjugated streptavidin (BioLegend). Colorimetric reaction was developed and measured as above.</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Histochemical assays</title>
<p>Spleens from infected and uninfected mice were frozen in liquid nitrogen. Seven &#x3bc;m thick cryosections were obtained and then fixed in acetone for 10 min at -20 &#xb0;C and air-dried for 10 min. They were then rehydrated in TRIS buffer and blocked for 30 min at RT with TRIS-10% normal mouse serum. Subsequently, sections were incubated for 1h at RT in a humid chamber with different combinations of fluorochrome-conjugated antibodies in TRIS buffer. Finally, sections were mounted with FluorSave (Merck Millipore) and observed under an Olympus FV 1000 confocal microscope. Images were processed with Adobe Photoshop.</p>
<p>Antibodies and reagents used were Alexa Fluor 488-labelled anti-mouse CD4 and Alexa Fluor 647 labelled peanut agglutinin (PNA, Invitrogen), and PE-labelled anti-mouse B220 (eBioscience).</p>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>Quantitative analysis of GC architecture</title>
<p>This analysis was performed using <italic>QuPath</italic> software (version 0.5.1). For each spleen section, three representative fields containing clearly identifiable B cell follicles (B220<sup>+</sup>) were selected. B cell follicles were manually annotated based on B220 staining, while GCs were identified and annotated based on strong PNA positivity and concurrent downregulation of B220 expression. Regions of interest (ROIs) corresponding to follicles (yellow) and GCs (cyan) were defined manually for all groups in a blinded fashion. The following parameters were measured: Follicle area (&#xb5;m&#xb2;): total area of each annotated B220<sup>+</sup> follicle; GC area (&#xb5;m&#xb2;): total area of PNA<sup>+</sup> regions within each follicle; GC area per field (&#xb5;m&#xb2;): total GC area normalized to the entire field of view; GC/follicle ratio: calculated as the ratio of total GC area to its corresponding follicle area for each ROI pair; GC circularity: used as a geometric metric of structural organization, calculated using the formula: Circularity = (4 &#xd7; &#x3c0; &#xd7; Area)/(Perimeter&#xb2;). Circularity values range from 0 to 1, with values closer to 1 indicating more regular, circular shapes. Circularity was computed in QuPath via a custom Groovy script that extracted area and perimeter measurements and stored circularity as a new annotation measurement. Data from at least three independent animals per group were pooled for quantification. Measurements were exported from QuPath and analyzed in GraphPad Prism for statistical analysis.</p>
</sec>
<sec id="s2_11">
<label>2.11</label>
<title>Statistics</title>
<p>Statistical significance of comparisons of mean values was assessed by Shapiro-Wilk test for normality then by using two-tailed Student&#x2019;s <italic>t</italic>-test and ANOVA, followed by Bonferroni&#x2019;s <italic>post-hoc</italic> test and a Gehan-Breslow-Wilcoxon test. Data in follicles area were analyzed using one-way ANOVA with &#x160;&#xed;d&#xe1;k&#x2019;s multiple comparisons test. All assays were performed with GraphPad Prism software. At least 4&#x2013;5 animals were included in each group.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>The absence of Gal-8 enables the persistence of chronic splenomegaly during <italic>T. cruzi</italic> infection</title>
<p>To investigate the role of Galectin-8 (Gal-8) in the inflammatory environment induced by <italic>T. cruzi</italic>, we used a chronic infection model. Gal-8-deficient (Gal-8KO) and wild-type (WT) mice were infected with <italic>T. cruzi</italic> Ac strain, model in which we previously observed comparable parasitemia levels and survival rates (80%) between the two experimental groups (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A, B</bold>
</xref>) (<xref ref-type="bibr" rid="B9">Bertelli et&#xa0;al., 2020</xref>). The development of cardiac inflammation and fibrosis was observed, as expected for <italic>T. cruzi</italic> chronic infection (at 4 mpi), although the absence of Gal-8 enhanced the inflammation level (<xref ref-type="bibr" rid="B9">Bertelli et&#xa0;al., 2020</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>iGal-8KO mice showed persistent splenomegaly in the chronic phase of infection. WT and Gal-8KO mice were infected with Ac strain of T. cruzi. <bold>(A)</bold> Survival curves. <bold>(B)</bold> Parasitemia curves. <bold>(C)</bold> Weight of spleens obtained along the infection and of uninfected mice. D-F obtained at 4 mpi: <bold>(D)</bold> Spleen weight, <bold>(E)</bold> Total number of cells/spleen. <bold>(F)</bold> Macroscopical image of spleens from infected mice. Spleens of uninfected controls are shown as reference. No variations in body weight or parasite load were found between infected WT or KO mice. Rule is in cm. Data are expressed as mean &#xb1; SEM of a representative assay. At least three independent experiments were performed. Statistical significance of comparisons of mean values was assessed using one-way ANOVA followed by Bonferroni&#x2019;s post-hoc test. *<italic>p</italic>&lt;0.05; **<italic>p</italic>&lt;0.01; ****<italic>p</italic>&lt;0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1625938-g001.tif">
<alt-text content-type="machine-generated">Graphical data showing experimental results across multiple panels. Panel (A) displays a survival curve, with iWT and iGal-8KO groups showing near identical survival rates over 160 days post-infection (dpi). Panel (B) depicts parasites per milliliter, peaking around 30 dpi in both groups. Panel (C) shows spleen weight changes over time, with iGal-8KO and WT groups diverging significantly. Panel (D) compares spleen weight among groups, showing higher weights in iGal-8KO. Panel (E) presents splenocyte counts, highest in iGal-8KO. Panel (F) illustrates physical spleens from each group with notable size differences.</alt-text>
</graphic>
</fig>
<p>According to previous reports indicating that <italic>T. cruzi</italic> induces splenomegaly (<xref ref-type="bibr" rid="B45">Lopes et&#xa0;al., 1995</xref>; <xref ref-type="bibr" rid="B24">Dehesa-Rodriguez et&#xa0;al., 2022</xref>), both iWT and iGal-8KO mice exhibited pronounced splenomegaly during the acute phase of the infection. In agreement with other murine models <bold>((</bold>
<xref ref-type="bibr" rid="B23">de Alba Alvarado et&#xa0;al., 2023</xref>) and reviewed in Talvani and Teixeira (<xref ref-type="bibr" rid="B77">Talvani and Teixeira, 2011</xref>)<bold>),</bold> in our model the acute phase last at 2 mpi when parasitemia values became undetectable by microscopic analysis and the splenomegaly resolution starts in the iWT mouse (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1B, C</bold>
</xref>). However, spleens of iGal-8KO mice showed significant increase that persisted as long as 6 mpi when compared to those from iWT mice (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). Measures of weight, total number of splenocytes together with an illustration of the spleens collected at 4 mpi are shown in <xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1D-F</bold>
</xref>. This unexpected result suggests that the absence of Gal-8 disrupts the resolution of spleen expansion during the chronic phase of infection. All the assays of this study were conducted at 4mpi.</p>
<p>It is noteworthy that body weight of iWT and iGal-8KO mice remained similar throughout the infection. The parasite load, assessed by qPCR, was also similar between both groups (iWT 1,9 &#xb1; 0,9 <italic>vs</italic>. iGal8KO 2,3 &#xb1; 0,9 parasite equivalents/50ng DNA). Furthermore, spleens weight from non-infected Gal-8KO mice exhibited similar values to those from non-infected WT mice.</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Cellular immune populations implicated in chronic splenomegaly</title>
<p>To identify the cellular populations contributing to the persistence of chronic splenomegaly observed in iGal-8KO mice, we conducted an in-depth analysis of immune splenic cells at 4 mpi, a time point when splenomegaly is being resolved in iWT mice.</p>
<sec id="s3_2_1">
<label>3.2.1</label>
<title>Myeloid cells number is increased in the spleen of iGal-8KO mice</title>
<p>The analysis of splenic myeloid cells, characterized by the CD11b surface marker, showed an increase in absolute numbers in iGal-8KO mice compared to iWT, with no differences observed between uninfected groups (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). Further analysis of myeloid subpopulations revealed that the spleens of iGal-8KO mice exhibited significantly higher absolute numbers of monocytes (CD11b<sup>+</sup> Ly6C<sup>+</sup> Ly6G<sup>-</sup>), neutrophils (CD11b<sup>+</sup> Ly6G<sup>+</sup> Ly6C<sup>+</sup>), and dendritic cells (CD11c<sup>+</sup> F4/80<sup>-</sup>) compared to the spleens of iWT mice (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2B-D</bold>
</xref>). In contrast, the absolute number of macrophages (CD11b<sup>+</sup> F4/80<sup>+</sup>) was similarly increased in both iWT and iGal-8KO groups (iWT: 3.4&#xb1; 0.7; iG8: 4.9 &#xb1; 0.65) while no differences were observed between uninfected mice (WT: 0.5 &#xb1; 0.14; G8: 0.6 &#xb1; 0.11).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>iGal-8KO mice showed increased number of myeloid cells. WT and Gal-8KO mice were infected with Ac strain of <italic>T. cruzi.</italic> At 4 mpi cells were obtained from spleens of iWT and iGal-8KO mice and their respective uninfected control groups. Statistical analysis of absolute number of: <bold>(A)</bold> Myeloid cells/spleen (CD11b<sup>+</sup>), <bold>(B)</bold> Monocytes/spleen (CD11b<sup>+</sup> Ly6C<sup>+</sup> Ly6G<sup>-</sup>), <bold>(C)</bold> Neutrophiles/spleen (CD11b<sup>+</sup> Ly6C<sup>+</sup> Ly6G<sup>+</sup>) and <bold>(D)</bold> Dendritic cells/spleen (CD11c<sup>+</sup> F4/80<sup>-</sup>). Data are expressed as mean &#xb1; SEM of a representative assay. At least three independent experiments were performed. Panel used for flow cytometry staining: CD11c-FITC; CD11b-PE; F480-PerCP; Ly6G-PE-Cy7; and Ly6C-APC. Statistical significance of comparisons of mean values was assessed using one-way ANOVA followed by Bonferroni&#x2019;s <italic>post-hoc</italic> test. *<italic>p</italic>&lt;0.05; **<italic>p</italic>&lt;0.01; ***<italic>p</italic>&lt;0.001; ****<italic>p</italic>&lt;0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1625938-g002.tif">
<alt-text content-type="machine-generated">Bar charts labeled A to D compare cell types: myeloid cells, monocytes, neutrophils, and dendritic cells across four groups: WT, iWT, Gal-8KO, and iGal-8KO. iGal-8KO consistently shows a significant increase across all cell types. Statistically significant differences are noted with asterisks.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_2_2">
<label>3.2.2</label>
<title>Impact of Galectin-8 deficiency on B cell function and germinal center formation</title>
<p>Considering the immunomodulatory role that many proteins from the galectin family play in the B cell immune response (<xref ref-type="bibr" rid="B73">Sharma et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B87">Tsai et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B63">Rabinovich and Croci, 2012</xref>; <xref ref-type="bibr" rid="B6">Beccaria et&#xa0;al., 2018</xref>), and given that the predominant leukocyte population in this organ is composed of B cells, we conducted a detailed analysis of this population. Examination of the B compartment revealed that, although infected mice showed higher absolute numbers of B cells compared to their uninfected controls, there were no differences between iWT and iGal-8KO mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>). Since the B compartment is composed of different subsets that fulfill diverse functions (<xref ref-type="bibr" rid="B41">LeBien and Tedder, 2008</xref>), we next assessed the representation of each subpopulation in the spleen of infected and uninfected mice using the B220, CD19, CD21 and CD23 antibody panel.</p>
<p>Cell subsets were defined as follicular B cells (FO: B220<sup>+</sup> CD19<sup>+</sup> CD21<sup>int</sup> CD23<sup>+</sup>), marginal zone B cells (MZ: B220<sup>+</sup> CD19<sup>+</sup> CD21<sup>high</sup> CD23<sup>low</sup>), and transitional/immature B cells (T1: B220<sup>+</sup> CD19<sup>+</sup> CD21<sup>low</sup> CD23<sup>low</sup>) (<xref ref-type="bibr" rid="B41">LeBien and Tedder, 2008</xref>) (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). FO, the prevailing subset of the splenic B compartment, and T1 cells showed similar absolute numbers between infected mice (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3B, C</bold>
</xref>); whereas MZ cells were significantly decreased in iGal-8 KO mice compared to iWT (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>). The evaluation of the antibody-secreting cells (ASC) population, based on the expression of B220 and CD138 surface markers, together with the analysis of expressing B220<sup>+</sup> FAS<sup>+</sup> GL7<sup>+</sup> germinal center B cells (GC), revealed that iGal-8KO mice had higher absolute numbers of ASC and GC in their spleen than iWT mice (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3E-G</bold>
</xref>). These data show that each infected group of mice presented consistent ASC and GC values.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>iGal-8KO mice present increased germinal center B cells and antibody secreting cell numbers. Evaluation, by flow cytometry, of different B cell subsets in the spleen of iWT and iGal-8KO mice obtained at 4 mpi. <bold>(A)</bold> Representative density dot plots of transitional B cells T1 (B220<sup>+</sup> CD19<sup>+</sup> CD21<sup>low</sup> CD23<sup>low</sup>), FO (B220<sup>+</sup> CD19<sup>+</sup> CD21<sup>int</sup> CD23<sup>+</sup>) B cells and MZ (B220<sup>+</sup> CD19<sup>+</sup> CD21<sup>high</sup> CD23<sup>low</sup>) B cells. Statistical analysis of the absolute number of <bold>(B)</bold> T1 B cells/spleen, <bold>(C)</bold> FO B cells/spleen and <bold>(D)</bold> MZ B cells/spleen in infected mice and control groups. <bold>(E)</bold> Representative density dot plots of GC B cells (B220<sup>+</sup> CD19<sup>+</sup> FAS<sup>+</sup> GL7<sup>+</sup>). Statistical analysis of the absolute number of <bold>(F)</bold> GC B cells/spleen and <bold>(G)</bold> ASC/spleen (B220<sup>+</sup> CD138<sup>+</sup>). Data are expressed as mean &#xb1; SEM of a representative assay. At least three independent experiments were performed. Panels used for flow cytometry staining: CD21-FITC; B220-PE; CD23-PerCP; and CD19-PE-Cy7 <bold>(A&#x2013;D)</bold>; CD19-FITC; FAS-PE; CD138-PerCP; B220-PE-Cy7; and GL7-APC <bold>(E&#x2013;G)</bold>. Statistical significance of comparisons of mean values was assessed using one-way ANOVA followed by Bonferroni&#x2019;s <italic>post-hoc</italic> test. *<italic>p</italic>&lt;0.05; **<italic>p</italic>&lt;0.01; ****<italic>p</italic>&lt;0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1625938-g003.tif">
<alt-text content-type="machine-generated">Flow cytometry and bar chart analysis of B cell populations in different genotypes: WT, iWT, Gal-8KO, and iGal-8KO. Panels (A) and (E) display flow plots for CD21/CD23 and FAS/GL7 markers, highlighting marginal zone, follicular, transitional, and germinal center B cells. Panels (B), (C), (D), (F), and (G) show bar graphs quantifying transitional, follicular, marginal zone, germinal center B cells, and antibody-secreting cells, with statistical significance indicated by asterisks.</alt-text>
</graphic>
</fig>
<p>Given the importance of architecture, polarization, and regionalization of GCs within B cell follicles in ensuring their functionality (<xref ref-type="bibr" rid="B50">Mesin et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B22">Cyster and Allen, 2019</xref>; <xref ref-type="bibr" rid="B89">Victora and Nussenzweig, 2022</xref>), we aimed to evaluate these aspects in iGal-8KO mice. To address this, we performed immunofluorescence staining on spleen sections from infected and uninfected mice (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). The spleens of uninfected mice, both WT and Gal-8 KO, showed well-preserved follicular B cell structures with no evidence of GCs. As expected, spleens from iWT mice exhibited peanut agglutinin (PNA)-positive structures within follicles, forming GCs with a conserved, round architecture. In contrast, iGal-8KO mice displayed multiple heterogeneous PNA<sup>+</sup> structures within B cell follicles, accompanied by marked microarchitectural disorganization. To quantitatively assess these differences, we measured several structural parameters. Follicle area did not differ significantly across groups (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>), while the total GC area itself (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>) and per field (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>) were significantly reduced in iGal-8KO mice compared to iWT controls. Furthermore, the ratio of GC to follicle area (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>), used to estimate the proportion of the follicle engaged in GC response, was markedly lower in iGal-8 KO mice. We also analyzed GC circularity (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>) as a geometric measure of GC organization and structural integrity. Well-formed GCs typically exhibit a round morphology, whereas irregular or fragmented GCs show reduced circularity. In line with this, GCs in iGal-8KO mice displayed significantly lower circularity values compared to iWT (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>). To study the functional capacity of GC we have analyzed the avidity of sera antibodies by ELISA and expressed them as the ratio of absorbance/absorbance after 6M urea treatment of sera (see Materials and Methods). Results obtained 1,871 &#xb1; 0,2071 (iWT) and 1,966 &#xb1; 0,1548 (iGal-8KO) showed no significative differences between infected groups (n=8 in each group).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>iGal-8KO mice present disorganized Germinal Centers in the chronic phase of the infection. <bold>(A)</bold> Immunofluorescence of spleen sections from iWT and iGal-8KO mice obtained at 4 mpi and their respective controls, stained with anti-B220 (red), anti-CD4 (green) and peanut agglutinin (PNA, blue). Note the presence of GC in the iWT and the disorganized GC in the iGal-8KO mice. Bar 100 &#xb5;m. <bold>(B)</bold> Follicles area in infected and control mice groups. <bold>(C)</bold> GC area, <bold>(D)</bold> GC area per field, <bold>(E)</bold> GC-to-follicle area ratio in infected mice. <bold>(F)</bold> GC circularity in infected mice and control groups. Data from at least three independent animals per group were pooled for quantification. Data in <bold>(B)</bold> were analyzed using one-way ANOVA with &#x160;&#xed;d&#xe1;k&#x2019;s multiple comparisons test. Data in all other graphs were analyzed using two-tailed Students&#x2019; <italic>t</italic>-test. *<italic>p</italic>&lt;0.05; **<italic>p</italic>&lt;0.01; ns, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1625938-g004.tif">
<alt-text content-type="machine-generated">Panel A displays fluorescence microscopy images of different sample groups (WT, iWT, Gal-8KO, iGal-8KO) at magnifications of 10X, 20X, and 40X, showing varied staining patterns in red, green, and blue. Panel B presents a violin plot comparing follicle areas, while panels C to F show violin plots analyzing germinal center area, GC area per field, GC/follicle ratio, and circularity between iWT and iGal-8 KO groups, respectively, with asterisks indicating significance levels.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_2_3">
<label>3.2.3</label>
<title>T lymphocytes as the main contributors to chronic splenomegaly persistence</title>
<p>Flow cytometry analysis revealed the expansion of CD4<sup>+</sup> and CD8<sup>+</sup> T cell populations after <italic>T. cruzi</italic> infection (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A, B</bold>
</xref>). Notably, the absolute numbers of T cells were significantly higher in iGal-8KO mice compared to iWT.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>CD4<sup>+</sup> and CD8<sup>+</sup> T cells are significantly increased in iGal-8KO mice. The frequency of splenic T cell populations was analyzed by flow cytometry in iWT and iGal-8KO mice obtained at 4 mpi. Statistical analysis of the absolute number of <bold>(A)</bold> CD4<sup>+</sup> T cells/spleen, <bold>(B)</bold> CD8<sup>+</sup> T cells/spleen, <bold>(C)</bold> Naive CD4<sup>+</sup> T cells/spleen (CD44<sup>-</sup> CD62L<sup>+</sup>); <bold>(D)</bold> Naive CD8<sup>+</sup> T cells/spleen (CD44<sup>-</sup> CD62L<sup>+</sup>); <bold>(E)</bold> CD4<sup>+</sup> effector T cells/spleen (CD44<sup>+</sup> CD62L<sup>-</sup>); <bold>(F)</bold> CD8<sup>+</sup> effector T cells/spleen (CD44<sup>+</sup> CD62L<sup>-</sup>); <bold>(G)</bold> CD8<sup>+</sup> central memory T cells/spleen (CD44<sup>+</sup> CD62L<sup>+</sup>); <bold>(H)</bold> CD4<sup>+</sup> central memory T cells/spleen (CD44<sup>+</sup> CD62L<sup>+</sup>). Evaluation was carried out in the spleen of iWT and iGal-8KO mice 4 mpi. Data are expressed as mean &#xb1; SEM of a representative assay. At least three independent experiments were performed. Panel used for flow cytometry staining: CD44-FITC; CD62L-PerCP; CD8-APC; and CD4-APC-Cy7. Statistical significance of comparisons of mean values was assessed using one-way ANOVA followed by Bonferroni&#x2019;s <italic>post-hoc</italic> test. *<italic>p</italic>&lt;0.05; **<italic>p</italic>&lt;0.01; ***<italic>p</italic>&lt;0.001; ****<italic>p</italic>&lt;0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1625938-g005.tif">
<alt-text content-type="machine-generated">Eight bar graphs labeled (A) to (H) compare different types of T cells (CD4+ and CD8+) across four groups: WT, iWT, Gal-8KO, and iGal-8KO. Significant differences are shown with asterisks and lines. Each graph displays data with varying cell counts, highlighting differences between the groups. Error bars indicate variability within the groups.</alt-text>
</graphic>
</fig>
<p>T cells are classified into na&#xef;ve, central memory and effector phenotypes based on the expression of CD62L (L-selectin) and CD44. Specifically, CD44<sup>-</sup> CD62L<sup>+</sup> cells are identified as na&#xef;ve, CD44<sup>+</sup> CD62L<sup>+</sup> cells represent the central memory subset, and CD44<sup>+</sup> CD62L<sup>-</sup> cells correspond to the effector subpopulation (<xref ref-type="bibr" rid="B58">Nolz et&#xa0;al., 2011</xref>). The analysis of these subsets revealed that both CD4<sup>+</sup> and CD8<sup>+</sup> populations in iGal-8KO mice had significantly higher absolute numbers of na&#xef;ve (CD44<sup>-</sup> CD62L<sup>+</sup>) and effector (CD44<sup>+</sup> CD62L<sup>-</sup>) T cells compared to iWT mice (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5C-F</bold>
</xref>). Only CD8<sup>+</sup> central memory cells (CD44<sup>+</sup> CD62L<sup>+</sup>) showed an increase in iGal-8KO mice (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5G</bold>
</xref>), whereas no differences were observed in CD4<sup>+</sup> central memory cells between infected groups (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5H</bold>
</xref>).</p>
<p>It is known that a proper balance between Treg and effector T cells is important for controlling the magnitude and quality of the adaptative immune response. In our analysis, we observed a significant decrease in the frequency of total Foxp3<sup>+</sup> Tregs in infected mice compared to their uninfected controls (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>). There were no differences in the absolute number of Tregs between iWT and iGal-8KO mice (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>). We then evaluated the expression of key functional suppressive proteins in Tregs, including CTLA-4 and CD39 (<xref ref-type="bibr" rid="B76">Takenaka et&#xa0;al., 2016</xref>). This revealed a significant increase in the percentage of Tregs expressing CTLA-4 and CD39 in iGal-8KO mice compared to iWT (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6C, D</bold>
</xref>).We next analyzed the CD4 T cell populations involved in supporting and regulating the humoral immune response. This analysis included T follicular helper cells (Tfh), which support GC responses and are characterized as CD4<sup>+</sup> CXCR5<sup>+</sup> ICOS<sup>+</sup> Foxp3<sup>-</sup>, and T follicular regulatory cells (Tfr), which limit GC responses and are defined as CD4<sup>+</sup> CXCR5<sup>+</sup> ICOS<sup>+</sup> Foxp3<sup>+</sup> B220<sup>-</sup> (<xref ref-type="bibr" rid="B62">Qi, 2016</xref>; <xref ref-type="bibr" rid="B90">Vinuesa et&#xa0;al., 2016</xref>). Significant differences were detected only between infected and uninfected mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;2A, B</bold>
</xref>). The coefficient between the frequency of Tfh and Tfr cells was evaluated (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2C</bold>
</xref>), since it is a parameter associated with the amplitude of humoral immune responses (<xref ref-type="bibr" rid="B92">Xu et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B31">Fan et&#xa0;al., 2018</xref>). Despite this coefficient being increased in infected mice compared to their uninfected controls, no differences were observed between iWT and iGal-8KO mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2C</bold>
</xref>). Results indicate that Gal-8 deficiency leads to an increase in effector T cell subsets without a change in Treg numbers, suggesting an imbalance in the T cell compartment.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>iGal-8KO mice did not show alterations in the development of regulatory T cells. <bold>(A)</bold> Frequency of regulatory T cells Foxp3<sup>+</sup> (percentages depicted within CD4<sup>+</sup> subset). <bold>(B)</bold> Absolute number of regulatory T cells/spleen (CD4<sup>+</sup> Foxp3<sup>+</sup>) and its relationship with the total number of lymphoid cells/spleen, uninfected animals&#x2019; values were: WT cells: 58.91 &#xb1; 6.84; WT Treg: 1.24 &#xb1; 0.25; Gal-8KO cells: 49.4 &#xb1; 3.2; Gal-8KO Treg: 1.66 &#xb1; 0.25. <bold>(C)</bold> CTLA-4<sup>+</sup> and <bold>(D)</bold> CD39<sup>+</sup> expression in regulatory T cells (percentages depicted within CD4<sup>+</sup> Foxp3<sup>+</sup> subset). Evaluation was carried out in the spleens of iWT and iGal-8KO mice 4 mpi. Data are expressed as mean &#xb1; SEM of a representative assay. At least three independent experiments were performed. Panel used for flow cytometry staining: CTLA4-PE; FoxP3-PerCP; CD39-APC; and CD4-APC-Cy7. Statistical significance of comparisons of mean values was assessed using one-way ANOVA followed by Bonferroni&#x2019;s <italic>post-hoc</italic> test <bold>(A, C, D)</bold> and two-tailed Student&#x2019;s <italic>t</italic>-test <bold>(B)</bold>. *<italic>p</italic>&lt;0.05; **<italic>p</italic>&lt;0.01; ***<italic>p</italic>&lt;0.001; ****<italic>p</italic>&lt;0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1625938-g006.tif">
<alt-text content-type="machine-generated">Bar charts labeled A to D display immunological data. Chart A shows the percentage of CD4+ Foxp3+ cells across four groups: WT, iWT, Gal-8KO, and iGal-8KO, with significant differences noted. Chart B illustrates total cell numbers in iWT and iGal-8KO groups. Charts C and D depict percentages of CD4+ Foxp3+ CTLA-4+ and CD4+ Foxp3+ CD39+ cells, respectively, among the same groups, also with noted significant differences. Statistical significance is indicated by asterisks, with more asterisks indicating higher significance.</alt-text>
</graphic>
</fig>
<p>Next, the lymphocyte proliferative ability was analyzed in splenocyte cultures. Splenocytes obtained from infected and uninfected mice were allowed to proliferate for 24 (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>) and 48h (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>) without stimulus. When recently isolated, the iGal-8KO cells displayed a highly increased proliferative ability. Under stimulation with parasite antigens, iGal-8KO cells again showed significative increased proliferative activity respect to iWT cells. Several relevant cytokines (IL-2, IL-4, IL-6, IL-10, IL-17, TNF and IFN&#x3b3;) levels were tested in the supernatants of splenocyte cultures stimulated with <italic>T. cruzi</italic> antigen (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3</bold>
</xref>). Although all cytokine levels were increased in supernatants obtained from infected mice compared to their uninfected controls, only IL-6 showed higher levels in iGal-8KO supernatants compared to iWT.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Splenocytes from iGal-8KO mice showed increased proliferation. Cells were obtained from spleens of iWT and iGal-8KO mice at 4 mpi and their respective control groups. Statistical analysis of <bold>(A)</bold> the basal proliferation index after 24 h of culture and <bold>(B)</bold> the basal proliferation index after 48 h of culture, with or without re-stimulation with specific antigen. Analysis was performed by incorporation of tritiated thymidine. Statistical analysis of the frequency of <bold>(C)</bold> Ki-67<sup>+</sup> CD4<sup>+</sup> T cells (percentages depicted within CD4<sup>+</sup> subset), <bold>(D)</bold> Ki-67<sup>+</sup> CD8<sup>+</sup> T cells (percentages depicted within CD8<sup>+</sup> subset) and <bold>(E)</bold> Ki-67<sup>+</sup> B220<sup>+</sup>cells (percentages depicted within B220<sup>+</sup> subset). Data are expressed as mean &#xb1; SEM of at least three independent experiments. Panel used for flow cytometry staining: Ki67-PE; CD8-APC; B220-PE-Cy7 and CD4-APC-Cy7. Statistical significance of comparisons of mean values was assessed using one-way ANOVA followed by Bonferroni&#x2019;s <italic>post-hoc</italic> test. *<italic>p</italic>&lt;0.05; **<italic>p</italic>&lt;0.01; ***<italic>p</italic>&lt;0.001; ****<italic>p</italic>&lt;0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1625938-g007.tif">
<alt-text content-type="machine-generated">Bar graphs showing experimental data for different mouse models: WT, iWT, Gal-8KO, and iGal-8KO.   (A) Shows counts per minute (cpm) with significant differences.  (B) Shows cpm with and without stimulus, highlighting significant activity increase in iGal-8KO.  (C) Displays %CD4+ Ki67+ T cells, higher in iGal-8KO.  (D) Shows %CD8+ Ki67+ T cells, with notable increases in iWT and iGal-8KO.  (E) Exhibits %B220+ Ki67+ cells, with iWT showing significant elevation. Error bars represent standard deviation, and asterisks indicate significance levels.</alt-text>
</graphic>
</fig>
<p>To identify the proliferating cells, we analyzed the expression of Ki-67 marker in both B and T compartments (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>). Flow cytometry analysis revealed a higher percentage of Ki-67<sup>+</sup> CD4<sup>+</sup> and Ki-67<sup>+</sup> CD8<sup>+</sup> T cells in the spleen of iGal-8KO mice in comparison to their counterpart in iWT (<xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7C, D</bold>
</xref>) consistent with the observed increase in the absolute number of these populations (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A, B</bold>
</xref>). In contrast, B220<sup>+</sup> proliferation rates were similar between infected mice (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7E</bold>
</xref>), which agrees with the previously described absolute numbers of B cells (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>). Thus, the differences in thymidine incorporation can be ascribed to T cell populations. Taken together, our results indicate that, beside the increased number of innate immune cells, CD4<sup>+</sup> and CD8<sup>+</sup> T cells emerge as the primary contributors to the persistence of chronic splenomegaly observed in iGal-8KO mice.</p>
</sec>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Gal-8 deficiency does not induce chronic splenomegaly in <italic>Toxoplasma gondii</italic> infection</title>
<p>To analyze whether the chronic persistence of splenomegaly was a widespread phenomenon that could be reproduced in the absence of Gal-8, we used another chronic infectious scenario, the infection with <italic>Toxoplasma gondii</italic>. This parasite induces a chronic murine infection characterized by acute splenomegaly, which begins to resolve at about 3 weeks post-infection (<xref ref-type="bibr" rid="B42">Li et&#xa0;al., 2021</xref>).</p>
<p>The progression of <italic>T. gondii</italic> infection showed no variations between the infected groups. Parasite load, evaluated by counting brain cysts, revealed comparable values between iWT and iGal-8KO mice at 45, 60 and 90 dpi (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8</bold>
</xref>). Moreover, both infected groups displayed similar survival. Splenomegaly rates values were similar in both groups, over the 90 dpi tested (shown for 60 dpi in <xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8</bold>
</xref>). Flow cytometry analysis also revealed no significant differences in the absolute number of B cells, T cells (CD4<sup>+</sup> and CD8<sup>+</sup>), monocytes, macrophages, neutrophils, and dendritic cells, (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;4</bold>
</xref>). These results show that the lack of Gal-8 is not a sufficient requirement to sustain chronic splenomegaly induced by <italic>T. gondii</italic>.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Gal-8 absence did not induce chronic splenomegaly during <italic>Toxoplasma gondii</italic> infection. WT and Gal-8KO mice were infected with the <italic>T. gondii</italic> Me49 strain and analysis was performed at 60 dpi. <bold>(A)</bold> Total numbers of cysts/brain. <bold>(B)</bold> Survival rate. <bold>(C)</bold> Spleen weight. Data are expressed as mean &#xb1; SEM of a representative assay. At least three independent experiments were performed. Statistical significance of comparisons of mean values was assessed using two-tailed Student&#x2019;s <italic>t</italic>-test <bold>(A)</bold> and one-way ANOVA followed by Bonferroni&#x2019;s <italic>post-hoc</italic> test <bold>(C)</bold>. Survival rates were compared using Gehan-Breslow-Wilcoxon test <bold>(B)</bold>. **<italic>p</italic>&lt;0.01; ****<italic>p</italic>&lt;0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1625938-g008.tif">
<alt-text content-type="machine-generated">Three graphs labeled A, B, and C. (A) Bar graph comparing cyst numbers between iWT and iGal-8 KO groups, showing higher numbers in the iWT group. (B) Line graph depicting survival percentage over days post-infection (dpi) for iWT and iGal-8 KO, with both maintaining near 100% survival. (C) Bar graph comparing spleen weight among WT, iWT, Gal-8 KO, and iGal-8 KO groups, showing significantly higher spleen weight in the iGal-8 KO group, denoted by asterisks.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>The immune system is regulated by a complex network of interactors, including Gals. Currently, Gals are considered potential therapeutic targets to control chronic inflammatory processes in autoimmune or infectious diseases (<xref ref-type="bibr" rid="B64">Rabinovich and Toscano, 2009</xref>). In particular, the role of Gal-8 in the activation of the immune system is variable depending on the cellular context. While it promotes the activation of effector functions, such as inducing platelet activation (<xref ref-type="bibr" rid="B68">Romaniuk et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B17">Cattaneo et&#xa0;al., 2014</xref>), co-stimulation (<xref ref-type="bibr" rid="B83">Tribulatti et&#xa0;al., 2009</xref>) and T lymphocyte proliferation (<xref ref-type="bibr" rid="B84">Tribulatti et&#xa0;al., 2012</xref>), several studies have reported an immunosuppressive role for this galectin in Jurkat cells (<xref ref-type="bibr" rid="B59">Norambuena et&#xa0;al., 2009</xref>), in CD4<sup>+</sup>CD8<sup>+</sup> thymocytes (<xref ref-type="bibr" rid="B82">Tribulatti et&#xa0;al., 2007</xref>) and in models of autoimmune diseases (<xref ref-type="bibr" rid="B71">Sampson et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B60">Pardo et&#xa0;al., 2017</xref>).</p>
<p>Our study on the role of Gal-8 in the inflammatory context induced during chronic <italic>T. cruzi</italic> infection showed its anti-inflammatory property (<xref ref-type="bibr" rid="B9">Bertelli et&#xa0;al., 2020</xref>). Here, we describe and analyze the persistence of splenomegaly in the chronic phase of <italic>T. cruzi</italic> infection in mice lacking Gal-8. Although there are several hypothesis and findings supporting the development of splenomegaly based in the high immune reactivity during the acute phase of the infection, there is scant information regarding the recovery of organ size. In our model, during the acute phase, the occurrence of splenomegaly, evaluated as organ weight, was similar between the infected groups (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). After 2 mpi, and as it progresses towards the chronic phase, splenomegaly was reduced in iWT mice. However, in iGal-8KO mice this did not occurs (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1C-F</bold>
</xref>). At 4 mpi, we observed significant differences in the weight of the spleen and in the number of splenocytes in iGal-8KO animals compared to iWT (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1D-F</bold>
</xref>). This phenomenon is associated to the infection, since neither the weight nor the total number of splenocytes were altered by the absence of this galectin in uninfected mice. In human Chagas disease, splenomegaly has been described during the acute phase in infections acquired by different routes, including vectorial, congenital and organ transplants (<xref ref-type="bibr" rid="B93">Zaidenberg and Segovia, 1993</xref>; <xref ref-type="bibr" rid="B57">Moya et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B8">Bern et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B12">Cabrera et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B32">Fernandez-Villegas et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B28">Echeverria and Morillo, 2019</xref>). In all cases, splenomegaly resolves after the acute phase is controlled, as occurs in the mouse model. Therefore, this model could provide important clues to understanding the resolution of splenomegaly, the associated events of which are still unknown.</p>
<p>Lymphocytes B response to <italic>T. cruzi</italic> acquires an important role in controlling the spread and maintaining low levels of parasitemia in the chronic phase (<xref ref-type="bibr" rid="B3">Amezcua Vesely et&#xa0;al., 2012</xref>). At 4 mpi, the analysis of the expression of different phenotypic markers in B cells, allowed us to study the role of Gal-8 in the humoral immune response against the parasite. We observed an increased number of transitional B lymphocytes in infected mice (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>), that could be related with the known polyclonal activation of B cells (<xref ref-type="bibr" rid="B3">Amezcua Vesely et&#xa0;al., 2012</xref>). iGal-8KO mice showed reduced cell numbers in the MZ population (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>). It is possible that this population, that respond rapidly to stimuli circulating in the blood, quickly differentiate into ASC or GC B cells (<xref ref-type="bibr" rid="B74">Song and Cerny, 2003</xref>; <xref ref-type="bibr" rid="B3">Amezcua Vesely et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B19">Cerutti et&#xa0;al., 2013</xref>). Therefore, it is not surprising that a decrease in MZ B lymphocytes is associated with an increase in GC B cells. The observed reduction in the number of MZ B cells does not necessarily indicate that these cells have not exerted or are not exerting their function. Simultaneously, a significant increase in the number of mature B lymphocytes occurs, as consequence of cellular division (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3F, G</bold>
</xref>). Cytometry evaluation showed increased number of GC B lymphocytes and ASC in iGal-8KO <italic>vs</italic> iWT mice (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3F, G</bold>
</xref>). Surprisingly, the evaluation in serum of total IgGs level and IgG1, IgG2a, IgG2b specific anti-<italic>T. cruzi</italic> subclasses values were similar between iWT and iGal-8KO mice (data not shown) as well as sera antibodies avidity. However, immunohistochemical assays showed in iGal-8KO that GCs, identified as PNA<sup>+</sup>, were highly disorganized (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>).</p>
<p>Gals have been involved in the development of B cells. Evidence have suggested that they play an important role in their signaling and activation (<xref ref-type="bibr" rid="B1">Acosta-Rodriguez et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B6">Beccaria et&#xa0;al., 2018</xref>) then they can influence cell fate decisions by regulating the balance between differentiation into memory or plasma cells. During <italic>T. cruzi</italic> infection, it was shown that Gal-3 in collaboration with IL-4, promotes differentiation into memory B cells at the expense of plasma cell differentiation (<xref ref-type="bibr" rid="B1">Acosta-Rodriguez et&#xa0;al., 2004</xref>). The absence of Gal-3 generates a higher number of ASC in response to other parasites challenge (<xref ref-type="bibr" rid="B11">Brand et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B81">Toscano et&#xa0;al., 2012</xref>) and also drives lupus-like disease by promoting spontaneous germinal centers in aged mice (<xref ref-type="bibr" rid="B6">Beccaria et&#xa0;al., 2018</xref>). In addition, Gal-1 and Gal-8 have been involved in the development of plasma cells. Gal-1 is significantly increased by B cell differentiation and is directly regulated by Blimp-1, in murine and human B cells (<xref ref-type="bibr" rid="B86">Tsai et&#xa0;al., 2008</xref>). However, Gal-1 would not be strictly essential since Gal-8 can functionally compensate for its absence, being the antibody production not affected (<xref ref-type="bibr" rid="B87">Tsai et&#xa0;al., 2011</xref>). In our model, we cannot rule out that the absence of Gal-8 might be compensated by another Gals. For instance, Gal-9, that belongs to the same family as Gal-8 and is related to the promotion, formation, differentiation, and survival of B-lineage cells, could be involved in these events (<xref ref-type="bibr" rid="B14">Cao et&#xa0;al., 2018</xref>). On the other hand, since Tfh cells are involved in GC formation, somatic hypermutation and affinity maturation (<xref ref-type="bibr" rid="B62">Qi, 2016</xref>), the significant increase of Tfh could impact promoting B-lineage development in iGal-8KO mice resulting in uncontrolled GC reactions (<xref ref-type="bibr" rid="B70">Sage and Sharpe, 2015</xref>).</p>
<p>The study of DCs showed their significant increase in the spleen of iGal-8KO mice (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). These cells have the capacity to activate and become potent antigen presenters. DCs are known to secrete chemokines that recruit different cell populations of the innate response. In addition, Gals can inhibit or increase the activation of these cells (<xref ref-type="bibr" rid="B85">Tribulatti et&#xa0;al., 2020</xref>), which could explain the increase in the total number of monocytes and neutrophils in this organ (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2B, C</bold>
</xref>). In turn, Gals can also modulate key cellular activities that leads to leukocyte recruitment, probably by affecting chemoattraction and/or cell adhesion, potentially through both extracellular and intracellular signaling pathways (<xref ref-type="bibr" rid="B43">Liu and Stowell, 2023</xref>). Furthermore, the increase in these myeloid populations could be associated with a possible extramedullary myelopoiesis in the spleen (<xref ref-type="bibr" rid="B75">Swirski et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B67">Robbins et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B94">Zick, 2022</xref>). This event has been described in other infectious processes such as those triggered by <italic>Plasmodium</italic> sp., <italic>Leishmania major</italic> and <italic>Ehrlichia muris</italic> (<xref ref-type="bibr" rid="B54">Mirkovich et&#xa0;al., 1986</xref>; <xref ref-type="bibr" rid="B46">MacNamara et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B7">Belyaev et&#xa0;al., 2013</xref>). The absence of Gal-8 could be favoring this phenomenon. As mentioned before, the most striking immunological event of acute <italic>T. cruzi</italic> infection is the polyclonal activation of lymphocytes, leading to immunosuppression and splenomegaly (<xref ref-type="bibr" rid="B52">Minoprio et&#xa0;al., 1989</xref>). An intense proliferative activity of either B cells, CD4<sup>+</sup> and CD8<sup>+</sup> T cells, specific or nonspecific (<xref ref-type="bibr" rid="B53">Minoprio et&#xa0;al., 1986</xref>) is unleashed. As the infection progresses, a decrease in splenomegaly and a specific immune response is developed that is essential to control parasite replication and the survival of the host. The spleen reduction was observed in iWT mice from day 60 pi, however iGal-8KO mice failed to carry out it (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). CD4<sup>+</sup> and CD8<sup>+</sup> T populations were increased in iGal-8KO mice compared to their iWT counterpart (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). Different authors have shown that Gal-8 is involved in Tregs differentiation modulating IL-2 and TGF-&#x3b2; signaling and thus, promoting cell death and inhibiting the proliferation of stimulated T cells through the increase of inhibitory molecules and the production of IL-10 (<xref ref-type="bibr" rid="B72">Sampson et&#xa0;al., 2016</xref>). This ability of Gal-8 generates in the murine model of autoimmune uveitis a decrease in the production of cytokines of the Th1 and Th17 pathways, favoring the decrease of the inflammatory process (<xref ref-type="bibr" rid="B71">Sampson et&#xa0;al., 2015</xref>). In addition, the role of Gal-8 as an immunosuppressor in experimental autoimmune encephalomyelitis was demonstrated. Mice deficient in this Gal show increased inflammatory levels leading to a more severe chronic phase due to a decrease in the regulatory population (<xref ref-type="bibr" rid="B60">Pardo et&#xa0;al., 2017</xref>). In addition, during <italic>T. cruzi</italic> infection, Tregs can induce a suppressive action on CD4<sup>+</sup>, CD8<sup>+</sup> T lymphocytes and on other populations such as antigen-presenting cells (<xref ref-type="bibr" rid="B4">Araujo Furlan et&#xa0;al., 2018</xref>). In our <italic>T. cruzi</italic> chronic murine model Gal-8 showed anti-inflammatory properties (<xref ref-type="bibr" rid="B9">Bertelli et&#xa0;al., 2020</xref>), similar results were observed in a Gal-8 deficient murine model of autoimmunity (<xref ref-type="bibr" rid="B60">Pardo et&#xa0;al., 2017</xref>). However, we did not observe differences in the total numbers of regulatory T cells (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A, B</bold>
</xref>) and IL-10 levels between infected groups (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3</bold>
</xref>). When analyzing phenotypic characteristics related to functional status of these regulatory cells, we found an increase in CTLA-4 and CD39 (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6C, D</bold>
</xref>), which suggests that the overexpression of these molecules in iGal-8KO mice could be a compensatory effect, since the same number of regulatory cells are involved in controlling twice the number of cells (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>).</p>
<p>The study of splenocytes proliferation showed that levels were indeed significantly increased in iGal-8KO mice (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>). Using Ki-67 we identified, by flow cytometry, that both CD4<sup>+</sup> and CD8<sup>+</sup> T-lineage populations were proliferating (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>). The status of this lineage showed that effector and memory cells were increased in the spleens of iGal-8KO mice (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). Increased proliferation in Gal-8KO, was accompanied by an increase in the production of IL-6 (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3</bold>
</xref>). IL-6 is a pleiotropic cytokine (<xref ref-type="bibr" rid="B39">Hunter and Jones, 2015</xref>) that enhances the immune response and has a strong pro-inflammatory ability (<xref ref-type="bibr" rid="B34">Gao and Pereira, 2002</xref>). While Gal-8 is known to exacerbate IL-6 production by DC stimulation (<xref ref-type="bibr" rid="B15">Carabelli et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B16">Carabelli et&#xa0;al., 2018</xref>), in this study we show that iGal-8KO mice produce higher levels of IL-6 than their iWT counterpart, supporting its induction by infection-derived stimuli. Depending on the context, IL-6 might play pro- or anti-inflammatory roles that can be protective in infectious diseases it helps solve, but deleterious in autoimmune affections associated with the chronic presence of this cytokine (<xref ref-type="bibr" rid="B39">Hunter and Jones, 2015</xref>). IL-6 is crucial for host survival from <italic>T. cruzi</italic> infection, as its absence leads to increased parasitemia and earlier mortality, appearing to play a role as a direct mediator of inflammation (<xref ref-type="bibr" rid="B34">Gao and Pereira, 2002</xref>). In our study we observed sustained IL-6 presence in the chronic phase of infection. Considering the persistent splenomegaly in the absence of Gal-8 and the increased titter of IL-6, it appears that a chronic inflammatory effect can also be attributed to this cytokine. Additionally, Gal 8 seems to modulate IL 6 production. Thus, IL-6 appears to be involved in both stages of infection, playing a protective role during the acute phase, and a detrimental one in the chronic phase, similar to what occurs during its sustained presence in several autoimmune diseases.</p>
<p>Gal-8 has been reported to induce apoptosis via different pathways such as the accumulation of p21, a cyclin-dependent kinase inhibitor that exhibits strong anti-apoptotic activity (<xref ref-type="bibr" rid="B37">Hadari et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B5">Arbel-Goren et&#xa0;al., 2005</xref>). CD4<sup>high</sup>CD8<sup>high</sup> thymocytes enter apoptosis via caspases activation, after being stimulated with Gal-8 (<xref ref-type="bibr" rid="B85">Tribulatti et&#xa0;al., 2020</xref>). Gal-8 stimulation in Jurkat T cells induces apoptosis via the phosphatidic acid mediated ERK1/2 activation pathway (<xref ref-type="bibr" rid="B59">Norambuena et&#xa0;al., 2009</xref>). It is interesting to highlight that different groups have demonstrated that human peripheral blood mononuclear cells (PBMCs) must be activated either by PHA or anti-CD3/CD28, in order to be sensitive to apoptosis induced by Gal-8 (<xref ref-type="bibr" rid="B59">Norambuena et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B18">Cattaneo et&#xa0;al., 2011</xref>). Then, it was proposed that Gal-8, together with other galectins that are able to kill activated T cells, contribute to T cells homeostasis (<xref ref-type="bibr" rid="B59">Norambuena et&#xa0;al., 2009</xref>). Given that the persistent increased cellularity in the spleens from iGal-8KO mice corresponds mainly to the T cell population (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>), we could hypothesize that this excessive proliferation would be related to the inability to activate apoptosis pathways.</p>
<p>In our efforts to deepen our knowledge of the role of this galectin in the development of chronic splenomegaly, we extended our analysis to chronic <italic>T. gondii</italic> infection in Gal-8KO and the counterpart mice. The spleen weight and cytometry populations studies didn&#x2019;t show differences between infected groups at different times of infection (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;4</bold>
</xref>), indicating that the induced splenomegaly persistence in Gal-8KO mouse is not a general event but a result of the interaction with the <italic>T. cruzi</italic> infection process.</p>
<p>Another issue to take in consideration, is that the absence of Gal-8 didn&#x2019;t modify parasitemia values nor mortality rate in <italic>T. cruzi</italic>-infected mice (<xref ref-type="bibr" rid="B9">Bertelli et&#xa0;al., 2020</xref>). Likewise, similar number of cerebral cysts and mortality values were observed in <italic>T. gondii</italic>-infected mice. Taken together, we can speculate that Gal-8 is not related to the events involved in protection, in the analyzed models. A compensatory mechanism by another galectin cannot be ruled out.</p>
<p>The Gal-8KO mouse model provides evidence supporting that the retraction of the acute splenomegaly is strongly related to Gal-8 participation during the <italic>T. cruzi</italic> infection, a parasite known as a stronger inducer of inflammation.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusions</title>
<p>-The murine model used allowed us, for the first time, to associate a specific molecule, Gal-8, with the resolution of acute splenomegaly induced by <italic>Trypanosoma cruzi</italic> infection.</p>
<p>-The absence of Gal-8 did not modify parasitic load or mortality rate in either <italic>Trypanosoma cruzi</italic>- or <italic>Toxoplasma gondii</italic>-infected mice.</p>
<p>-The generation of germinal centers is hampered in the absence of Gal-8 during the infection with <italic>Trypanosoma cruzi.</italic>
</p>
<p>-The absence of Gal-8 promotes increased proliferation of CD4<sup>+</sup> and CD8<sup>+</sup> T cells during <italic>Trypanosoma cruzi</italic> infection.</p>
<p>-Gal-8 plays an anti-inflammatory role in <italic>Trypanosoma cruzi</italic> infection.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by Committee for Experimental Animal Care and Use of the Universidad Nacional de San Mart&#xed;n (UNSAM). The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>AB: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Investigation, Formal analysis. JS: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing, Formal analysis, Investigation. CB: Investigation, Writing &#x2013; review &amp; editing, Formal analysis. LV: Resources, Writing &#x2013; review &amp; editing, Investigation. SA: Resources, Writing &#x2013; review &amp; editing. OC: Writing &#x2013; original draft, Resources, Funding acquisition, Validation, Conceptualization, Writing &#x2013; review &amp; editing. AG: Writing &#x2013; review &amp; editing, Validation, Supervision, Funding acquisition, Conceptualization. ML: Resources, Writing &#x2013; review &amp; editing, Funding acquisition, Supervision, Conceptualization, Writing &#x2013; original draft, Validation, Project administration, Visualization, Methodology, Formal analysis.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01AI116432 to AG and R01AI104531 to OC and by Agencia Nacional de Promoci&#xf3;n de la Investigaci&#xf3;n, el Desarrollo Tecnol&#xf3;gico y la Innovaci&#xf3;n (Agencia I+D+i, Argentina) under award numbers PICT 2021-00660 to MSL and 2018-01694 to OC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AB, JS, and CB are fellows and LV, SA, AG, OC, and ML are researchers from Consejo Nacional de Investigaciones Cient&#xed;ficas y Tecnol&#xf3;gicas (CONICET), Argentina.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>The authors are in debt with Marisa Sarmenti for technical assistance.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s13" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2025.1625938/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2025.1625938/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SM1" mimetype="application/pdf"/>
<supplementary-material xlink:href="DataSheet2.pdf" id="SM2" mimetype="application/pdf"/>
<supplementary-material xlink:href="DataSheet3.pdf" id="SM3" mimetype="application/pdf"/>
<supplementary-material xlink:href="DataSheet4.pdf" id="SM4" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Acosta-Rodr&#xed;guez</surname> <given-names>E. V.</given-names>
</name>
<name>
<surname>Montes</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Motr&#xe1;n</surname> <given-names>C. C.</given-names>
</name>
<name>
<surname>Zuniga</surname> <given-names>E. I.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>F. T.</given-names>
</name>
<name>
<surname>Rabinovich</surname> <given-names>G. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Galectin-3 mediates IL-4-induced survival and differentiation of B cells: functional cross-talk and implications during Trypanosoma cruzi infection</article-title>. <source>J. Immunol.</source> <volume>172</volume>, <fpage>493</fpage>&#x2013;<lpage>502</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.172.1.493</pub-id>, PMID: <pub-id pub-id-type="pmid">14688359</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albareda</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>De Rissio</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Tomas</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Serjan</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Alvarez</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Viotti</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Polyfunctional T cell responses in children in early stages of chronic Trypanosoma cruzi infection contrast with monofunctional responses of long-term infected adults</article-title>. <source>PloS Negl. Trop. Dis.</source> <volume>7</volume>, <elocation-id>e2575</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0002575</pub-id>, PMID: <pub-id pub-id-type="pmid">24349591</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amezcua Vesely</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Bermejo</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Montes</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Acosta-Rodr&#xed;guez</surname> <given-names>E. V.</given-names>
</name>
<name>
<surname>Gruppi</surname> <given-names>A</given-names>
</name>
</person-group>. (<year>2012</year>). <article-title>B-cell response during protozoan parasite infections</article-title>. <source>J. Parasitol. Res.</source> <volume>2012</volume>, <fpage>362131</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2012/362131</pub-id>, PMID: <pub-id pub-id-type="pmid">22315659</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Araujo Furlan</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Tosello Boari</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Rodriguez</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Canale</surname> <given-names>F. P.</given-names>
</name>
<name>
<surname>Fiocca Vernengo</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Boccardo</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Limited foxp3(+) regulatory T cells response during acute trypanosoma cruzi infection is required to allow the emergence of robust parasite-specific CD8(+) T cell immunity</article-title>. <source>Front. Immunol.</source> <volume>9</volume>, <elocation-id>2555</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.02555</pub-id>, PMID: <pub-id pub-id-type="pmid">30455700</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arbel-Goren</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Levy</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Ronen</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Zick</surname> <given-names>Y</given-names>
</name>
</person-group>. (<year>2005</year>). <article-title>Cyclin-dependent kinase inhibitors and JNK act as molecular switches, regulating the choice between growth arrest and apoptosis induced by galectin-8</article-title>. <source>J. Biol. Chem.</source> <volume>280</volume>, <fpage>19105</fpage>&#x2013;<lpage>19114</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M502060200</pub-id>, PMID: <pub-id pub-id-type="pmid">15753078</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beccaria</surname> <given-names>C. G.</given-names>
</name>
<name>
<surname>Amezcua Vesely</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Fiocca Vernengo</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Gehrau</surname> <given-names>R. C.</given-names>
</name>
<name>
<surname>Ramello</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Tosello Boari</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Galectin-3 deficiency drives lupus-like disease by promoting</article-title>. <source>spontaneous germinal centers formation via IFN-&#x3b3;. Nat. Commun.</source> <volume>9</volume>, <fpage>1628</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-018-04063-5</pub-id>, PMID: <pub-id pub-id-type="pmid">29691398</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belyaev</surname> <given-names>N. N.</given-names>
</name>
<name>
<surname>Biro</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Langhorne</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Potocnik</surname> <given-names>A. J</given-names>
</name>
</person-group>. (<year>2013</year>). <article-title>Extramedullary myelopoiesis in malaria depends on mobilization of myeloid-restricted progenitors by IFN-&#x3b3; induced chemokines</article-title>. <source>PloS Pathog.</source> <volume>9</volume>, <elocation-id>e1003406</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1003406</pub-id>, PMID: <pub-id pub-id-type="pmid">23762028</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bern</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>D. L.</given-names>
</name>
<name>
<surname>Gilman</surname> <given-names>R. H.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Acute and congenital Chagas disease</article-title>. <source>Adv. Parasitol.</source> <volume>75</volume>, <fpage>19</fpage>&#x2013;<lpage>47</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/B978-0-12-385863-4.00002-2</pub-id>, PMID: <pub-id pub-id-type="pmid">21820550</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertelli</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Sanmarco</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Pascuale</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Postan</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Aoki</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Leguizamon</surname> <given-names>M. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Anti-inflammatory role of galectin-8 during trypanosoma cruzi chronic infection</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>10</volume>, <elocation-id>285</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2020.00285</pub-id>, PMID: <pub-id pub-id-type="pmid">32714876</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bidon</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Brichory</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Bourguet</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Le Pennec</surname> <given-names>J. P.</given-names>
</name>
<name>
<surname>Dazord</surname> <given-names>L</given-names>
</name>
</person-group>. (<year>2001</year>). <article-title>Galectin-8: a complex sub-family of galectins</article-title>. <source>Int. J. Mol. Med.</source> <volume>8</volume>, <fpage>245</fpage>&#x2013;<lpage>250</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/ijmm.8.3.245</pub-id>, PMID: <pub-id pub-id-type="pmid">11494049</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brand</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>F. L.</given-names>
</name>
<name>
<surname>Takiya</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Palumbo Jr.</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hsu</surname> <given-names>D. K.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>F. T.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>The involvement of the spleen during chronic phase of Schistosoma mansoni infection in galectin-3-/- mice</article-title>. <source>Histol Histopathol</source> <volume>27</volume>, <fpage>1109</fpage>&#x2013;<lpage>1120</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.14670/HH-27.1109</pub-id>, PMID: <pub-id pub-id-type="pmid">22763883</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cabrera</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Vega</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Valderrama</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Cabanillas</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Fernandez</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Rodriguez</surname> <given-names>O.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>New focus of active transmission of Chagas disease in indigenous populations in the Peruvian Amazon basin</article-title>. <source>Rev. Soc. Bras. Med. Trop.</source> <volume>46</volume>, <fpage>367</fpage>&#x2013;<lpage>372</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/0037-8682-1195-2013</pub-id>, PMID: <pub-id pub-id-type="pmid">23856870</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname> <given-names>C. W.</given-names>
</name>
<name>
<surname>Eickhoff</surname> <given-names>C. S.</given-names>
</name>
<name>
<surname>Meza</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Blase</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Audette</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>D. H.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Th17 Cells Provide Mucosal Protection against Gastric Trypanosoma cruzi Infection</article-title>. <source>Infect. Immun.</source> <volume>89</volume>, <elocation-id>e0073820</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00738-20</pub-id>, PMID: <pub-id pub-id-type="pmid">33941576</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Alluqmani</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Buhari</surname> <given-names>F. H. M.</given-names>
</name>
<name>
<surname>Wasim</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>L. K.</given-names>
</name>
<name>
<surname>Quaile</surname> <given-names>A. T.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Galectin-9 binds IgM-BCR to regulate B cell signaling</article-title>. <source>Nat. Commun.</source> <volume>9</volume>, <fpage>3288</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-018-05771-8</pub-id>, PMID: <pub-id pub-id-type="pmid">30120235</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carabelli</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Quattrocchi</surname> <given-names>V.</given-names>
</name>
<name>
<surname>D'antuono</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Zamorano</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Tribulatti</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Campetella</surname> <given-names>O.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Galectin-8 activates dendritic cells and stimulates antigen-specific immune response elicitation</article-title>. <source>J. Leukoc. Biol.</source> <volume>102</volume>, <fpage>1237</fpage>&#x2013;<lpage>1247</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1189/jlb.3A0816-357RR</pub-id>, PMID: <pub-id pub-id-type="pmid">28811319</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carabelli</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Prato</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Sanmarco</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Aoki</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Campetella</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Tribulatti</surname> <given-names>M. V.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Interleukin-6 signalling mediates Galectin-8 co-stimulatory activity of antigen-specific CD4 T-cell response</article-title>. <source>Immunology</source> <volume>155</volume>, <fpage>379</fpage>&#x2013;<lpage>386</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imm.12980</pub-id>, PMID: <pub-id pub-id-type="pmid">29972692</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cattaneo</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Tribulatti</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Carabelli</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Carestia</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Schattner</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Campetella</surname> <given-names>O.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Galectin-8 elicits pro-inflammatory activities in the endothelium</article-title>. <source>Glycobiology</source> <volume>24</volume>, <fpage>966</fpage>&#x2013;<lpage>973</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/glycob/cwu060</pub-id>, PMID: <pub-id pub-id-type="pmid">24957054</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cattaneo</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Tribulatti</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Campetella</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2011</year>). <italic>Galectin-8 tandem-repeat structure is essential for T-cell proliferation but not for co-stimulation</italic>. <source>Biochem. J.</source> <volume>434</volume>, <fpage>153</fpage>&#x2013;<lpage>160</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BJ20101691</pub-id>, PMID: <pub-id pub-id-type="pmid">21091438</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerutti</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Cols</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Puga</surname> <given-names>I.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes</article-title>. <source>Nat. Rev. Immunol.</source> <volume>13</volume>, <fpage>118</fpage>&#x2013;<lpage>132</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri3383</pub-id>, PMID: <pub-id pub-id-type="pmid">23348416</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cossarizza</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>H. D.</given-names>
</name>
<name>
<surname>Radbruch</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Abrignani</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Addo</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Akdis</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)</article-title>. <source>Eur. J. Immunol.</source> <volume>51</volume>, <fpage>2708</fpage>&#x2013;<lpage>3145</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.202170126</pub-id>, PMID: <pub-id pub-id-type="pmid">34910301</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cummings</surname> <given-names>K. L.</given-names>
</name>
<name>
<surname>Tarleton</surname> <given-names>R. L.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR</article-title>. <source>Mol. Biochem. Parasitol.</source> <volume>129</volume>, <fpage>53</fpage>&#x2013;<lpage>59</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0166-6851(03)00093-8</pub-id>, PMID: <pub-id pub-id-type="pmid">12798506</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cyster</surname> <given-names>J. G.</given-names>
</name>
<name>
<surname>Allen</surname> <given-names>C. D. C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>B cell responses: cell interaction dynamics and decisions</article-title>. <source>Cell</source> <volume>177</volume>, <fpage>524</fpage>&#x2013;<lpage>540</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2019.03.016</pub-id>, PMID: <pub-id pub-id-type="pmid">31002794</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Alba Alvarado</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Torres Gutierrez</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Cabrera Bravo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Zenteno Galindo</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Villarreal Munoz</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Salazar Schettino</surname> <given-names>P. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Main cardiac histopathologic alterations in the acute phase of trypanosoma cruzi infection in a murine model</article-title>. <source>Pathogens</source> <volume>12</volume>, <elocation-id>1084</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/pathogens12091084</pub-id>, PMID: <pub-id pub-id-type="pmid">37764892</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dehesa-Rodriguez</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Bastida-Jaime</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Espinoza</surname> <given-names>B</given-names>
</name>
</person-group>. (<year>2022</year>). <article-title>Trypanosoma cruzi blood trypomastigotes induce intense skeletal and cardiac muscle damage and Th1/Th2 immune response in the acute phase of mice infected by the oral route</article-title>. <source>Acta Trop.</source> <volume>234</volume>, <fpage>106605</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.actatropica.2022.106605</pub-id>, PMID: <pub-id pub-id-type="pmid">35820470</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Medeiros Brito</surname> <given-names>R. M.</given-names>
</name>
<name>
<surname>Meurer</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Batista</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>De Sa</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>De Medeiros Souza</surname> <given-names>C. R.</given-names>
</name>
<name>
<surname>De Souto</surname> <given-names>J. T.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Chronic Toxoplasma gondii infection contributes to perineuronal nets impairment in the primary somatosensory cortex</article-title>. <source>Parasit Vectors</source> <volume>15</volume>, <fpage>487</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13071-022-05596-x</pub-id>, PMID: <pub-id pub-id-type="pmid">36566237</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Sousa</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Vermeij</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Ramos Jr.</surname> <given-names>A. N.</given-names>
</name>
<name>
<surname>Luquetti</surname> <given-names>A. O</given-names>
</name>
</person-group>. (<year>2024</year>). <article-title>Chagas disease</article-title>. <source>Lancet</source> <volume>403</volume>, <fpage>203</fpage>&#x2013;<lpage>218</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(23)01787-7</pub-id>, PMID: <pub-id pub-id-type="pmid">38071985</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duarte</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Ribeiro</surname> <given-names>G. P.</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>A.</given-names>
</name>
<name>
<surname>De Souza</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Avila</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>De Oliveira</surname> <given-names>L. F. F.</given-names>
</name>
<etal/>
</person-group>. (<year>2025</year>). <article-title>CD4(+)T(H)17 cells play a critical role in conferring resistance to Trypanosoma cruzi infection while also demonstrating potential in mitigating the development of severe cardiac complications</article-title>. <source>Life Sci.</source> <volume>378</volume>, <fpage>123815</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2025.123815</pub-id>, PMID: <pub-id pub-id-type="pmid">40544953</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Echeverria</surname> <given-names>L. E.</given-names>
</name>
<name>
<surname>Morillo</surname> <given-names>C. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>American trypanosomiasis (Chagas disease)</article-title>. <source>Infect. Dis. Clin. North Am.</source> <volume>33</volume>, <fpage>119</fpage>&#x2013;<lpage>134</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.idc.2018.10.015</pub-id>, PMID: <pub-id pub-id-type="pmid">30712757</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elola</surname> <given-names>M. T.</given-names>
</name>
<name>
<surname>Ferragut</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Cardenas Delgado</surname> <given-names>V. M.</given-names>
</name>
<name>
<surname>Nugnes</surname> <given-names>L. G.</given-names>
</name>
<name>
<surname>Gentilini</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Laderach</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Expression, localization and function of galectin-8, a tandem-repeat lectin, in human tumors</article-title>. <source>Histol Histopathol</source> <volume>29</volume>, <fpage>1093</fpage>&#x2013;<lpage>1105</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.14670/HH-29.1093</pub-id>, PMID: <pub-id pub-id-type="pmid">24696431</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eshkar Sebban</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Ronen</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Levartovsky</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Elkayam</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Caspi</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Aamar</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation</article-title>. <source>J. Immunol.</source> <volume>179</volume>, <fpage>1225</fpage>&#x2013;<lpage>1235</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.179.2.1225</pub-id>, PMID: <pub-id pub-id-type="pmid">17617615</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Demers</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Wan</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Q</given-names>
</name>
</person-group>. (<year>2018</year>). <article-title>Altered ratio of t follicular helper cells to t follicular regulatory cells correlates with autoreactive antibody response in simian immunodeficiency virus&#x2013;Infected rhesus macaques</article-title>. <source>J. Immunol.</source> <volume>200</volume>, <fpage>3180</fpage>&#x2013;<lpage>3187</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1701288</pub-id>, PMID: <pub-id pub-id-type="pmid">29610141</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez-Villegas</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Thomas</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Carrilero</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Tellez</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Maranon</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Murcia</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>The innate immune response status correlates with a divergent clinical course in congenital Chagas disease of twins born in a non-endemic country</article-title>. <source>Acta Trop.</source> <volume>140</volume>, <fpage>84</fpage>&#x2013;<lpage>90</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.actatropica.2014.08.006</pub-id>, PMID: <pub-id pub-id-type="pmid">25149352</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fux</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Rodrigues</surname> <given-names>C. V.</given-names>
</name>
<name>
<surname>Portela</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>N. M.</given-names>
</name>
<name>
<surname>Su</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Sibley</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2003</year>). <article-title>Role of cytokines and major histocompatibility complex restriction in mouse resistance to infection with a natural recombinant strain (type I-III) of Toxoplasma gondii</article-title>. <source>Infect. Immun.</source> <volume>71</volume>, <fpage>6392</fpage>&#x2013;<lpage>6401</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.71.11.6392-6401.2003</pub-id>, PMID: <pub-id pub-id-type="pmid">14573660</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>M. A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Interleukin-6 is required for parasite</article-title>. <source>specific response Host resistance to Trypanosoma cruzi. Int. J. Parasitol.</source> <volume>32</volume>, <fpage>167</fpage>&#x2013;<lpage>170</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0020-7519(01)00322-8</pub-id>, PMID: <pub-id pub-id-type="pmid">11812493</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ramos</surname> <given-names>C. O.</given-names>
</name>
<name>
<surname>Senra</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>Vilas-Boas</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Rodrigues</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Campos-De-Carvalho</surname> <given-names>A. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Treatment with benznidazole during the chronic phase of experimental Chagas&#x2019; disease decreases cardiac alterations</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>49</volume>, <fpage>1521</fpage>&#x2013;<lpage>1528</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.49.4.1521-1528.2005</pub-id>, PMID: <pub-id pub-id-type="pmid">15793134</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gorosito Serran</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Tosello Boari</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Fiocca Vernengo</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Beccaria</surname> <given-names>C. G.</given-names>
</name>
<name>
<surname>Ramello</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Bermejo</surname> <given-names>D. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Unconventional pro-inflammatory CD4(+) T cell response in B cell-deficient mice infected with trypanosoma cruzi</article-title>. <source>Front. Immunol.</source> <volume>8</volume>, <elocation-id>1548</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.01548</pub-id>, PMID: <pub-id pub-id-type="pmid">29209313</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hadari</surname> <given-names>Y. R.</given-names>
</name>
<name>
<surname>Arbel-Goren</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Levy</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Amsterdam</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Alon</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Zakut</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2000</year>). <article-title>Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis</article-title>. <source>J. Cell Sci.</source> <volume>113</volume>, <fpage>2385</fpage>&#x2013;<lpage>2397</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/jcs.113.13.2385</pub-id>, PMID: <pub-id pub-id-type="pmid">10852818</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoft</surname> <given-names>D. F.</given-names>
</name>
<name>
<surname>Eickhoff</surname> <given-names>C. S.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges</article-title>. <source>Infect. Immun.</source> <volume>70</volume>, <fpage>6715</fpage>&#x2013;<lpage>6725</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.70.12.6715-6725.2002</pub-id>, PMID: <pub-id pub-id-type="pmid">12438346</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hunter</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>S. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>IL-6 as a keystone cytokine in health and disease</article-title>. <source>Nat. Immunol.</source> <volume>16</volume>, <fpage>448</fpage>&#x2013;<lpage>457</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.3153</pub-id>, PMID: <pub-id pub-id-type="pmid">25898198</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Tarleton</surname> <given-names>R. L.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice</article-title>. <source>J. Immunol.</source> <volume>166</volume>, <fpage>4596</fpage>&#x2013;<lpage>4603</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.166.7.4596</pub-id>, PMID: <pub-id pub-id-type="pmid">11254717</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>LeBien</surname> <given-names>T. W.</given-names>
</name>
<name>
<surname>Tedder</surname> <given-names>T. F.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>B lymphocytes: how they develop and function</article-title>. <source>Blood</source> <volume>112</volume>, <fpage>1570</fpage>&#x2013;<lpage>1580</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2008-02-078071</pub-id>, PMID: <pub-id pub-id-type="pmid">18725575</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Su</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Mei</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Dynamic expressions of TIGIT on splenic T cells and TIGIT-mediated splenic T cell dysfunction of mice with chronic toxoplasma gondii infection</article-title>. <source>Front. Microbiol.</source> <volume>12</volume>, <elocation-id>700892</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2021.700892</pub-id>, PMID: <pub-id pub-id-type="pmid">34421855</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>F.-T.</given-names>
</name>
<name>
<surname>Stowell</surname> <given-names>S. R.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The role of galectins in immunity and infection</article-title>. <source>Nat. Rev. Immunol.</source> <volume>23</volume>, <fpage>479</fpage>&#x2013;<lpage>494</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41577-022-00829-7</pub-id>, PMID: <pub-id pub-id-type="pmid">36646848</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Llaguno</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Da Silva</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Batista</surname> <given-names>L. R.</given-names>
</name>
<name>
<surname>Da Silva</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>De Sousa</surname> <given-names>R. C.</given-names>
</name>
<name>
<surname>De Resende</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>T-cell immunophenotyping and cytokine production analysis in patients with chagas disease 4 years after benznidazole treatment</article-title>. <source>Infect. Immun.</source> <volume>87</volume>, <fpage>e00103</fpage>&#x2013;<lpage>19</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00103-19</pub-id>, PMID: <pub-id pub-id-type="pmid">31085707</pub-id></citation></ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopes</surname> <given-names>M. F.</given-names>
</name>
<name>
<surname>Cunha</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Bezerra</surname> <given-names>F. L.</given-names>
</name>
<name>
<surname>Gonzalez</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Lapa Silva</surname> <given-names>E. J. R.</given-names>
</name>
<etal/>
</person-group>. (<year>1995</year>). <article-title>Trypanosoma cruzi: both chemically induced and triatomine-derived metacyclic trypomastigotes cause the same immunological disturbances in the infected mammalian host</article-title>. <source>Exp. Parasitol.</source> <volume>80</volume>, <fpage>194</fpage>&#x2013;<lpage>204</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/expr.1995.1024</pub-id>, PMID: <pub-id pub-id-type="pmid">7895831</pub-id></citation></ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macnamara</surname> <given-names>K. C.</given-names>
</name>
<name>
<surname>Oduro</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>D. D.</given-names>
</name>
<name>
<surname>Mclaughlin</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-&#x3b3; signaling</article-title>. <source>J. Immunol.</source> <volume>186</volume>, <fpage>1032</fpage>&#x2013;<lpage>1043</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1001893</pub-id>, PMID: <pub-id pub-id-type="pmid">21149601</pub-id></citation></ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magalhaes</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Villani</surname> <given-names>F. N.</given-names>
</name>
<name>
<surname>Nunes Mdo</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Gollob</surname> <given-names>K. J.</given-names>
</name>
<name>
<surname>Rocha</surname> <given-names>M. O.</given-names>
</name>
<name>
<surname>Dutra</surname> <given-names>W. O.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>High interleukin 17 expression is correlated with better cardiac function in human Chagas disease</article-title>. <source>J. Infect. Dis.</source> <volume>207</volume>, <fpage>661</fpage>&#x2013;<lpage>665</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/infdis/jis724</pub-id>, PMID: <pub-id pub-id-type="pmid">23204182</pub-id></citation></ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marcipar</surname> <given-names>I. S.</given-names>
</name>
<name>
<surname>Risso</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Silber</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Revelli</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Marcipar</surname> <given-names>A. J</given-names>
</name>
</person-group>. (<year>2001</year>). <article-title>Antibody maturation in Trypanosoma cruzi-infected rats</article-title>. <source>Clin. Diagn. Lab. Immunol.</source> <volume>8</volume>, <fpage>802</fpage>&#x2013;<lpage>805</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CDLI.8.4.802-805.2001</pub-id>, PMID: <pub-id pub-id-type="pmid">11427430</pub-id></citation></ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marin-Neto</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Cunha-Neto</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Maciel</surname> <given-names>B. C.</given-names>
</name>
<name>
<surname>Simoes</surname> <given-names>M. V</given-names>
</name>
</person-group>. (<year>2007</year>). <article-title>Pathogenesis of chronic Chagas heart disease</article-title>. <source>Circulation</source> <volume>115</volume>, <fpage>1109</fpage>&#x2013;<lpage>1123</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.624296</pub-id>, PMID: <pub-id pub-id-type="pmid">17339569</pub-id></citation></ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mesin</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Ersching</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Victora</surname> <given-names>G. D.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Germinal center B cell dynamics</article-title>. <source>Immunity</source> <volume>45</volume>, <fpage>471</fpage>&#x2013;<lpage>482</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2016.09.001</pub-id>, PMID: <pub-id pub-id-type="pmid">27653600</pub-id></citation></ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minoprio</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Parasite polyclonal activators: new targets for vaccination approaches</article-title>? <source>Int. J. Parasitol.</source> <volume>31</volume>, <fpage>588</fpage>&#x2013;<lpage>591</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0020-7519(01)00171-0</pub-id>, PMID: <pub-id pub-id-type="pmid">11334946</pub-id></citation></ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minoprio</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Itohara</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Heusser</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Tonegawa</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Coutinho</surname> <given-names>A</given-names>
</name>
</person-group>. (<year>1989</year>) <article-title>Immunobiology of murine T. cruzi infection: the predominance of parasite-nonspecific responses and the activation of TCRI T cells</article-title>. <source>Immunol. Rev.</source> <volume>112</volume>, <fpage>183</fpage>&#x2013;<lpage>2041989</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1600-065x.1989.tb00558.x</pub-id>, PMID: <pub-id pub-id-type="pmid">2514135</pub-id></citation></ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minoprio</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Coutinho</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Joskowicz</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lima</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Eisen</surname> <given-names>H</given-names>
</name>
</person-group>. (<year>1986</year>). <article-title>Polyclonal lymphocyte responses to murine trypanosoma cruzi infection: II. Cytotoxic T lymphocytes</article-title>. <source>Scand. J. Immunol.</source> <volume>24</volume>, <fpage>669</fpage>&#x2013;<lpage>679</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-3083.1986.tb02186.x</pub-id>, PMID: <pub-id pub-id-type="pmid">3099380</pub-id></citation></ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mirkovich</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Galelli</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Allison</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Modabber</surname> <given-names>F. Z</given-names>
</name>
</person-group>. (<year>1986</year>). <article-title>Increased myelopoiesis during Leishmania major infection in mice: generation of &#x2018;safe targets&#x2019;, a possible way to evade the effector immune mechanism</article-title>. <source>Clin. Exp. Immunol.</source> <volume>64</volume>, <fpage>1</fpage>&#x2013;<lpage>7</lpage>., PMID: <pub-id pub-id-type="pmid">3488146</pub-id></citation></ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montes</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Zuniga</surname> <given-names>E. I.</given-names>
</name>
<name>
<surname>Vazquez</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Arce</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Gruppi</surname> <given-names>A</given-names>
</name>
</person-group>. (<year>2002</year>). <article-title>Trypanosoma cruzi mitochondrial malate dehydrogenase triggers polyclonal B-cell activation</article-title>. <source>Clin. Exp. Immunol.</source> <volume>127</volume>, <fpage>27</fpage>&#x2013;<lpage>36</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2249.2002.01746.x</pub-id>, PMID: <pub-id pub-id-type="pmid">11882029</pub-id></citation></ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montes</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Acosta-Rodriguez</surname> <given-names>E. V.</given-names>
</name>
<name>
<surname>Mucci</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zuniga</surname> <given-names>E. I.</given-names>
</name>
<name>
<surname>Campetella</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Gruppi</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2006</year>). <article-title>A Trypanosoma cruzi antigen signals CD11b+ cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells</article-title>. <source>Eur. J. Immunol.</source> <volume>36</volume>, <fpage>1474</fpage>&#x2013;<lpage>1485</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.200535537</pub-id>, PMID: <pub-id pub-id-type="pmid">16688679</pub-id></citation></ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moya</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Basso</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Moretti</surname> <given-names>E.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Congenital Chagas disease in Cordoba, Argentina: epidemiological, clinical, diagnostic, and therapeutic aspects. Experience of 30 years of follow up</article-title>. <source>Rev. Soc. Bras. Med. Trop.</source> <volume>38 Suppl 2</volume>, <fpage>33</fpage>&#x2013;<lpage>40</lpage>., PMID: <pub-id pub-id-type="pmid">16482811</pub-id></citation></ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nolz</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Starbeck-Miller</surname> <given-names>G. R.</given-names>
</name>
<name>
<surname>Harty</surname> <given-names>J. T.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Naive, effector and memory CD8 T-cell trafficking: parallels and distinctions</article-title>. <source>Immunotherapy</source> <volume>3</volume>, <fpage>1223</fpage>&#x2013;<lpage>1233</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2217/imt.11.100</pub-id>, PMID: <pub-id pub-id-type="pmid">21995573</pub-id></citation></ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norambuena</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Metz</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Vicu&#xf1;a</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Pardo</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Oyanadel</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Galectin-8 induces apoptosis in Jurkat T cells by phosphatidic acid-mediated ERK1/2 activation supported by protein kinase A down-regulation</article-title>. <source>J. Biol. Chem.</source> <volume>284</volume>, <fpage>12670</fpage>&#x2013;<lpage>12679</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M808949200</pub-id>, PMID: <pub-id pub-id-type="pmid">19276072</pub-id></citation></ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pardo</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Carcamo</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Uribe-San Martin</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ciampi</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Segovia-Miranda</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Curkovic-Pena</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis</article-title>. <source>PloS One</source> <volume>12</volume>, <elocation-id>e0177472</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0177472</pub-id>, PMID: <pub-id pub-id-type="pmid">28650992</pub-id></citation></ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pineda</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Corvo</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Soto</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Fresno</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bonay</surname> <given-names>P</given-names>
</name>
</person-group>. (<year>2015</year>). <article-title>Interactions of human galectins with Trypanosoma cruzi: binding profile correlate with genetic clustering of lineages</article-title>. <source>Glycobiology</source> <volume>25</volume>, <fpage>197</fpage>&#x2013;<lpage>210</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/glycob/cwu103</pub-id>, PMID: <pub-id pub-id-type="pmid">25267603</pub-id></citation></ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qi</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>T follicular helper cells in</article-title>. <source>space-time. Nat. Rev. Immunol.</source> <volume>16</volume>, <fpage>612</fpage>&#x2013;<lpage>625</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri.2016.94</pub-id>, PMID: <pub-id pub-id-type="pmid">27573485</pub-id></citation></ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rabinovich</surname> <given-names>G. A.</given-names>
</name>
<name>
<surname>Croci</surname> <given-names>D. O.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer</article-title>. <source>Immunity</source> <volume>36</volume>, <fpage>322</fpage>&#x2013;<lpage>335</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2012.03.004</pub-id>, PMID: <pub-id pub-id-type="pmid">22444630</pub-id></citation></ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rabinovich</surname> <given-names>G. A.</given-names>
</name>
<name>
<surname>Toscano</surname> <given-names>M. A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Turning &#x2018;sweet&#x2019; on immunity: galectin-glycan interactions in immune tolerance and inflammation</article-title>. <source>Nat. Rev. Immunol.</source> <volume>9</volume>, <fpage>338</fpage>&#x2013;<lpage>352</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri2536</pub-id>, PMID: <pub-id pub-id-type="pmid">19365409</pub-id></citation></ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reina-San-Martin</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Degrave</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Rougeot</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Cosson</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Chamond</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Cordeiro-Da-Silva</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2000</year>). <article-title>A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase</article-title>. <source>Nat. Med.</source> <volume>6</volume>, <fpage>890</fpage>&#x2013;<lpage>897</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/78651</pub-id>, PMID: <pub-id pub-id-type="pmid">10932226</pub-id></citation></ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Risso</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Garbarino</surname> <given-names>G. B.</given-names>
</name>
<name>
<surname>Mocetti</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Campetella</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Gonzalez Cappa</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Buscaglia</surname> <given-names>C. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages</article-title>. <source>J. Infect. Dis.</source> <volume>189</volume>, <fpage>2250</fpage>&#x2013;<lpage>2259</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/420831</pub-id>, PMID: <pub-id pub-id-type="pmid">15181573</pub-id></citation></ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robbins</surname> <given-names>C. S.</given-names>
</name>
<name>
<surname>Chudnovskiy</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Rauch</surname> <given-names>P. J.</given-names>
</name>
<name>
<surname>Figueiredo</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Iwamoto</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Gorbatov</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions</article-title>. <source>Circulation</source> <volume>125</volume>, <fpage>364</fpage>&#x2013;<lpage>374</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.061986</pub-id>, PMID: <pub-id pub-id-type="pmid">22144566</pub-id></citation></ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romaniuk</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Tribulatti</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Cattaneo</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Lapponi</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Molinas</surname> <given-names>F. C.</given-names>
</name>
<name>
<surname>Campetella</surname> <given-names>O.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <italic>Human platelets express and are activated by galectin-8</italic>. <source>Biochem. J.</source> <volume>432</volume>, <fpage>535</fpage>&#x2013;<lpage>547</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BJ20100538</pub-id>, PMID: <pub-id pub-id-type="pmid">20858220</pub-id></citation></ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruiz Diaz</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Mucci</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Meira</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Bogliotti</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Musikant</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Leguizamon</surname> <given-names>M. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Trypanosoma cruzi trans-sialidase prevents elicitation of Th1 cell response via interleukin 10 and downregulates Th1 effector cells</article-title>. <source>Infect. Immun.</source> <volume>83</volume>, <fpage>2099</fpage>&#x2013;<lpage>2108</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00031-15</pub-id>, PMID: <pub-id pub-id-type="pmid">25754197</pub-id></citation></ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sage</surname> <given-names>P. T.</given-names>
</name>
<name>
<surname>Sharpe</surname> <given-names>A. H.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>T follicular regulatory cells in the regulation of B cell responses</article-title>. <source>Trends Immunol.</source> <volume>36</volume>, <fpage>410</fpage>&#x2013;<lpage>418</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.it.2015.05.005</pub-id>, PMID: <pub-id pub-id-type="pmid">26091728</pub-id></citation></ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sampson</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>Hasegawa</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Mulki</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Suryawanshi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>W. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Galectin-8 ameliorates murine autoimmune ocular pathology and promotes a regulatory T cell response</article-title>. <source>PloS One</source> <volume>10</volume>, <elocation-id>e0130772</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0130772</pub-id>, PMID: <pub-id pub-id-type="pmid">26126176</pub-id></citation></ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sampson</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>Suryawanshi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>W. S.</given-names>
</name>
<name>
<surname>Rabinovich</surname> <given-names>G. A.</given-names>
</name>
<name>
<surname>Panjwani</surname> <given-names>N. J. I</given-names>
</name>
</person-group>. (<year>2016</year>). <article-title>Galectin-8 promotes regulatory T-cell differentiation by modulating IL-2 and TGF&#x3b2; signaling</article-title>. <source>Immunol. Cell Biol.</source> <volume>94</volume>, <fpage>213</fpage>&#x2013;<lpage>219</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/icb.2015.72</pub-id>, PMID: <pub-id pub-id-type="pmid">26282995</pub-id></citation></ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sundararajan</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Suryawanshi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Veiga-Parga</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kuchroo</surname> <given-names>V. K.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <italic>T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses</italic>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>108</volume>, <fpage>19001</fpage>&#x2013;<lpage>19006</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1107087108</pub-id>, PMID: <pub-id pub-id-type="pmid">22052881</pub-id></citation></ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Cerny</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen</article-title>. <source>J. Exp. Med.</source> <volume>198</volume>, <fpage>1923</fpage>&#x2013;<lpage>1935</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20031498</pub-id>, PMID: <pub-id pub-id-type="pmid">14662910</pub-id></citation></ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swirski</surname> <given-names>F. K.</given-names>
</name>
<name>
<surname>Nahrendorf</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Etzrodt</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Wildgruber</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Cortez-Retamozo</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Panizzi</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Identification of sp<italic>lenic reservoir monocytes and their deployment to inflammatory sites</italic>
</article-title>. <source>Science</source> <volume>325</volume>, <fpage>612</fpage>&#x2013;<lpage>616</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1175202</pub-id>, PMID: <pub-id pub-id-type="pmid">19644120</pub-id></citation></ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takenaka</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Robson</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Quintana</surname> <given-names>F. J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Regulation of the T cell response by CD39</article-title>. <source>Trends Immunol.</source> <volume>37</volume>, <fpage>427</fpage>&#x2013;<lpage>439</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.it.2016.04.009</pub-id>, PMID: <pub-id pub-id-type="pmid">27236363</pub-id></citation></ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talvani</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Teixeira</surname> <given-names>M. M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Inflammation and Chagas disease some mechanisms and relevance</article-title>. <source>Adv. Parasitol.</source> <volume>76</volume>, <fpage>171</fpage>&#x2013;<lpage>194</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/B978-0-12-385895-5.00008-6</pub-id>, PMID: <pub-id pub-id-type="pmid">21884892</pub-id></citation></ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarleton</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Chagas disease etiology: autoimmunity or parasite persistence</article-title>? <source>Parasitol. Today</source> <volume>15</volume>, <fpage>94</fpage>&#x2013;<lpage>99</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0169-4758(99)01398-8</pub-id>, PMID: <pub-id pub-id-type="pmid">10322321</pub-id></citation></ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thijssen</surname> <given-names>V. L.</given-names>
</name>
<name>
<surname>Hulsmans</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Griffioen</surname> <given-names>A. W.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells</article-title>. <source>Am. J. Pathol.</source> <volume>172</volume>, <fpage>545</fpage>&#x2013;<lpage>553</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2353/ajpath.2008.070938</pub-id>, PMID: <pub-id pub-id-type="pmid">18202194</pub-id></citation></ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thurston</surname> <given-names>T. L.</given-names>
</name>
<name>
<surname>Wandel</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Von Muhlinen</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Foeglein</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Randow</surname> <given-names>F</given-names>
</name>
</person-group>. (<year>2012</year>). <article-title>Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion</article-title>. <source>Nature</source> <volume>482</volume>, <fpage>414</fpage>&#x2013;<lpage>418</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature10744</pub-id>, PMID: <pub-id pub-id-type="pmid">22246324</pub-id></citation></ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toscano</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Tongren</surname> <given-names>J.</given-names>
</name>
<name>
<surname>De Souza</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>F. T.</given-names>
</name>
<name>
<surname>Riley</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Rabinovich</surname> <given-names>G. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Endogenous galectin-3 controls experimental malaria in a</article-title>. <source>species-specific manner. Parasite Immunol.</source> <volume>34</volume>, <fpage>383</fpage>&#x2013;<lpage>387</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-3024.2012.01366.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22486577</pub-id></citation></ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tribulatti</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Mucci</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Cattaneo</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Aguero</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Gilmartin</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Head</surname> <given-names>S. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>Galectin-8 induces apoptosis in the CD4(high)CD8(high) thymocyte subpopulation</article-title>. <source>Glycobiology</source> <volume>17</volume>, <fpage>1404</fpage>&#x2013;<lpage>1412</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/glycob/cwm104</pub-id>, PMID: <pub-id pub-id-type="pmid">17893094</pub-id></citation></ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tribulatti</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Cattaneo</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Hellman</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Mucci</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Campetella</surname> <given-names>O</given-names>
</name>
</person-group>. (<year>2009</year>). <article-title>Galectin-8 provides costimulatory and proliferative signals to T lymphocytes</article-title>. <source>J. Leukoc. Biol.</source> <volume>86</volume>, <fpage>371</fpage>&#x2013;<lpage>380</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1189/jlb.0908529</pub-id>, PMID: <pub-id pub-id-type="pmid">19401394</pub-id></citation></ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tribulatti</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Figini</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Carabelli</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Cattaneo</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Campetella</surname> <given-names>O</given-names>
</name>
</person-group>. (<year>2012</year>). <article-title>Redundant and antagonistic functions of galectin-1, -3, and -8 in the elicitation of T cell responses</article-title>. <source>J. Immunol.</source> <volume>188</volume>, <fpage>2991</fpage>&#x2013;<lpage>2999</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1102182</pub-id>, PMID: <pub-id pub-id-type="pmid">22357632</pub-id></citation></ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tribulatti</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Carabelli</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Prato</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Campetella</surname> <given-names>O</given-names>
</name>
</person-group>. (<year>2020</year>). <article-title>Galectin-8 in the onset of the immune response and inflammation</article-title>. <source>Glycobiology</source> <volume>30</volume>, <fpage>134</fpage>&#x2013;<lpage>142</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/glycob/cwz077</pub-id>, PMID: <pub-id pub-id-type="pmid">31529033</pub-id></citation></ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Chiu</surname> <given-names>Y. K.</given-names>
</name>
<name>
<surname>Hsu</surname> <given-names>T. L.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>I. Y.</given-names>
</name>
<name>
<surname>Hsieh</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>K. I.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Galectin-1 promotes immunoglobulin production during plasma cell differentiation</article-title>. <source>J. Immunol.</source> <volume>181</volume>, <fpage>4570</fpage>&#x2013;<lpage>4579</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.181.7.4570</pub-id>, PMID: <pub-id pub-id-type="pmid">18802059</pub-id></citation></ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Guan</surname> <given-names>C. H.</given-names>
</name>
<name>
<surname>Hsieh</surname> <given-names>H. W.</given-names>
</name>
<name>
<surname>Hsu</surname> <given-names>T. L.</given-names>
</name>
<name>
<surname>Tu</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>K. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Galectin-1 and galectin-8 have redundant roles in promoting plasma cell formation</article-title>. <source>J. Immunol.</source> <volume>187</volume>, <fpage>1643</fpage>&#x2013;<lpage>1652</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1100297</pub-id>, PMID: <pub-id pub-id-type="pmid">21753146</pub-id></citation></ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Umekita</surname> <given-names>L. F.</given-names>
</name>
<name>
<surname>Mota</surname> <given-names>I.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi</article-title>? <source>Braz. J. Med. Biol. Res.</source> <volume>33</volume>, <fpage>253</fpage>&#x2013;<lpage>258</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/S0100-879X2000000300001</pub-id>, PMID: <pub-id pub-id-type="pmid">10719375</pub-id></citation></ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Victora</surname> <given-names>G. D.</given-names>
</name>
<name>
<surname>Nussenzweig</surname> <given-names>M. C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Germinal centers</article-title>. <source>Annu. Rev. Immunol.</source> <volume>40</volume>, <fpage>413</fpage>&#x2013;<lpage>442</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-120419-022408</pub-id>, PMID: <pub-id pub-id-type="pmid">35113731</pub-id></citation></ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinuesa</surname> <given-names>C. G.</given-names>
</name>
<name>
<surname>Linterman</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Maclennan</surname> <given-names>I. C</given-names>
</name>
</person-group>. (<year>2016</year>). <article-title>Follicular helper T cells</article-title>. <source>Annu. Rev. Immunol.</source> <volume>34</volume>, <fpage>335</fpage>&#x2013;<lpage>368</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-041015-055605</pub-id>, PMID: <pub-id pub-id-type="pmid">26907215</pub-id></citation></ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volta</surname> <given-names>B. J.</given-names>
</name>
<name>
<surname>Bustos</surname> <given-names>P. L.</given-names>
</name>
<name>
<surname>Gonzalez</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Natale</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Perrone</surname> <given-names>A. E.</given-names>
</name>
<name>
<surname>Milduberger</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Circulating cytokine and chemokine profiles of trypanosoma cruzi-infected women during pregnancy and its association with congenital transmission</article-title>. <source>J. Infect. Dis.</source> <volume>224</volume>, <fpage>1086</fpage>&#x2013;<lpage>1095</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/infdis/jiab057</pub-id>, PMID: <pub-id pub-id-type="pmid">33528501</pub-id></citation></ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>The ratio of circulating follicular T helper cell to follicular T regulatory cell is correlated with disease activity in systemic lupus erythematosus</article-title>. <source>J. Clin. Immunol.</source> <volume>183</volume>, <fpage>46</fpage>&#x2013;<lpage>53</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.clim.2017.07.004</pub-id>, PMID: <pub-id pub-id-type="pmid">28709914</pub-id></citation></ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaidenberg</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Segovia</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Congenital Chagas disease in the city of Salta, Argentina</article-title>. <source>Rev. Inst Med. Trop. Sao Paulo</source> <volume>35</volume>, <fpage>35</fpage>&#x2013;<lpage>43</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/S0036-46651993000100006</pub-id>
</citation></ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zick</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Galectin-8, cytokines, and the storm</article-title>. <source>Biochem. Soc. Trans.</source> <volume>50</volume>, <fpage>135</fpage>&#x2013;<lpage>149</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BST20200677</pub-id>, PMID: <pub-id pub-id-type="pmid">35015084</pub-id></citation></ref>
</ref-list>
</back>
</article>